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ABSTRACT 
The work presented in this dissertation addresses the need for an affordable point-of-care 
diagnostic tool for early detection of cancer. We identified a biomarker detection approach done 
using photonic crystal enhanced fluorescence (PCEF) instrumentation as the best way to achieve 
this goal. We introduce a model for predicting enhanced fluorescence (EF) performance of a 
photonic crystal (PC) in the context of a given set of instrument parameters as well as insights 
into instrument specific device design. From this we conclude that PCEF performance is a 
combined effect of the PC quality-factor (Q-factor) and the instrument angle of divergence. From 
a practical standpoint, a higher Q-factor gives a higher fluorescence enhancement but at the cost 
of higher variability in the fluorescence enhancement. To combat this we introduce a new angle-
scanning scheme that addresses any uniformity issues.  The resulting fluorescence enhancement 
is recorded to be >600× on a PC with respect to glass. 
The PC properties are further exploited to introduce a new label-free modality that allows 
for selective fluorescence enhancement as well as quality control for a protein microarray, 
helping to identify discrepancies in binding densities of antibodies. The angle-scanning 
technique coupled with the new modality shows a significant reduction in the coefficient of 
variation by 20-99% compared to ordinary fluorescence microscopy and a lowering of the 
detectable biomarker concentrations. 
 To further lower the detection limits and miniaturize the instrument size, the collimated 
illumination scheme was replaced by a line-focused scheme. The novel PC line-scanning method 
exploited the optical properties of a one-dimensional PC without significantly sacrificing the 
coupling efficiency. The higher power density of the approach relative to the collimated PCEF 
instrument resulted in improved detection limits. A compact objective-coupled design was 
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introduced to address the size demands of an ideal point-of-care system. The biomarker detection 
study comparing the line-scanning instrument performance with a commercial confocal scanner 
showed a >10× improvement in the detectable concentrations.  
Finally, in order to diversify the applicability of the objective coupled system, we 
modified the setup to incorporate a Raman detection scheme. A PC sensor with sparse surface 
distribution of gold nanorods was then coated with a monolayer of 4,4’-dipyridyl. The measured 
Raman scattering signal showed a 7× enhancement between the on and off-resonance cases.  
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CHAPTER 1.  INTRODUCTION 
In 2012, physicians and oncologists expect to diagnose 1.6 million new cancer cases 
across the United States [1]. The National Cancer Institute estimates nearly 600,000 Americans 
will die of cancer, cementing its position as the second leading cause of death in the United 
States. While it is widely acknowledged that the early detection of cancer can improve the five-
year survival rates of patients four-fold, studies conducted by the National Cancer Institute also 
suggest that the early detection of cancer is still highly subjective and depends on how 
perceptible a tumor is [1]. There is, consequently, no guarantee of a conclusive diagnosis in the 
early stages. That most forms of cancer are likely curable by conventional therapies if detected 
early enough is hence of little solace given the insidious nature of the disease and its over-
powering psychological hold. The burden of battling cancer, therefore, must begin with the 
ability to detect the disease early, earlier than is possible now. A rapid and predictable means of 
early diagnosis would allow cancer-treatment to be routine and remove the mystique of cancer as 
a malady with a sudden and violent onset. The early detection is a primary objective of cancer 
research with a high potential of improving both patients’ survival and quality of life [2]. 
The study of cancerous tissue has suggested that tumors, even at their earliest stages, 
exhibit characteristics distinct from normal tissues, which can be observed and measured via 
biomarkers in the blood [2, 3]. By studying the appropriate biomarkers it is conceivable that we 
can facilitate personalized medicine, including detection, diagnosis, prognosis, and monitoring of 
therapy. It is important here to note the distinction between the detection and diagnosis of cancer. 
For a test to be medically relevant it is essential to be able to unquestionably determine the 
presence of the disease. The use of biomedical imaging techniques of MRI, CT and X-ray (that 
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require expensive equipment and may potentially harm the patient) is still prominent as a means 
of diagnosis of cancer because these techniques allow for the identification of a cancerous tumor. 
These tests, however, require a patient to exhibit symptoms associated with cancer; i.e. the tumor 
must be sufficiently large. This practice of testing, after symptoms are presented, can often result 
in the diagnosis of disease at much later stages than is desirable for effective treatment. Thus, to 
have true early detection, it is imperative to develop assays and technology that are sensitive and 
specific enough to uncover the presence of cancer in asymptomatic patients. The ideal early-
diagnostic tool would be powerful enough not just to detect the presence of cancerous growths in 
the body but also to identify specific organs and sites in the body affected by the cancer. The use 
of blood biomarkers as an early detection tool promises to introduce a quantitative means of 
identifying the presence of site-specific cancer, making an otherwise clinically covert illness 
apparent [4-7]. 
Despite the promise of blood biomarkers, it is well recognized that these particular 
proteins have a high variability across individuals [4]. This necessitates the need to identify a 
panel of biomarkers to accurately diagnose and detect the presence of cancer. The financial 
investment associated with the research and development of a panel of diagnostic biomarkers 
that will likely be approved by the US food and drug administration is significant [4]. 
Furthermore, while the scientific and medical relevance of developing such a scheme has been 
well documented, the private sector is unwilling to invest resources into the development of 
these biomarkers owing to the lack of financial incentives.  
With the emergence and growing popularity of nanotechnology applications in biology, 
academic research has explored several avenues in search of the next revolutionary 
nanoproteomic tool for cancer biomarker detection. While numerous nanomaterial-based 
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approaches like microcantilevers [8], photonic microring resonators [9], optofluidic ring 
resonators [10], etc., have been investigated extensively, few techniques have come close to 
promising the level of success of the traditional enzyme linked immunosorbent assay (ELISA) 
based techniques.  
Electronic and electrochemical bio-detection methods have been extensively explored in 
recent years due to promising advantages in sensitivity, signal amplification, detection time and 
throughput. The most attractive technology among the potential candidates is carbon nanotube-
based cancer biomarker detection. Carbon nanotubes have the potential for fast and sensitive 
detection of cancer biomarkers in serum [11, 12]. Carbon nanotubes have been labeled with 
multiple enzyme layers to create an ultrasensitive chemiluminescence immunoassay that can 
lower the detection limit to 8 pg/ml, as much as two orders of magnitude lower than traditional 
sandwich ELISA. However, despite these promising results, this technology suffers from some 
major technical limitations like poor solubility in physiological conditions, the presence of metal 
impurities (that can reduce their activity) and the lack of well-established fabrication methods. 
Thus, the use of carbon nanotubes for developing highly multiplexed cancer biomarker assays 
that could serve as a viable alternative to ELISA is long way from being realized.  
With the consistent and steady rise of cancer cases across the United States and the 
world, there is an urgent demand for the development of diagnostic tools to meet current need. 
The greatest success has been promised, not by reinventing the wheel of cancer biomarker 
detection, but utilizing a variation of the already existing ELISA technique. Gold nanoparticles 
have been used in ELISA techniques to amplify the optical signal, promising improved assay 
sensitivity and reduced detection time [13, 14]. However the size and shape of gold nanoparticles 
often affect the efficacy of the detection process. Furthermore, the high probability of cross 
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reactivity adds to this list of concerns for multiplexed biomarker analysis. As an alternative 
approach to gold nanoparticles in ELISA assays, researchers have made use of quantum dots as 
attractive means to provide excellent fluorescence-based assays and circumvent many of the 
intrinsic limitations associated with organic dyes (narrow absorption and broad emission 
spectra). Quantum dots have also been demonstrated as an effective means of multiplexed 
biomarker detection owing to their high specificity, reduced non-specific binding, and freedom 
from the blocking and complex surface chemistry required by conventional microarrays. 
However, quantum dots have several limitations including lack of reproducibility, reduced 
luminescence due to the sensitivity to oxidation and photolysis, and most importantly concerns 
about their biocompatibility and toxic nature (due to free cadmium ions). Perhaps the most 
successful approach to multiplexed, sandwich ELISA-based biomarker analysis is the bead-
based approach (LUMINEX corp.). However, this approach typically demands the use of a much 
larger volume of blood than is available from a pin-prick, requires the off-site preparation of the 
assay and involves significant costs in labor and resources, all of which make it unsuitable for a 
true point-of-care diagnostic system. 
Thus, despite the investigation of several approaches for multiplexed biomarker analysis, 
it is widely accepted that in their present form most of these techniques lack the sensitivity 
and/or the adaptability to be viewed as viable point-of-care systems for early diagnosis of cancer 
owing to the need for detection of low-abundance protein biomarkers.  In order to overcome 
these limitations a photonic crystal biosensor exhibiting fluorescence enhancement has been 
proposed. 
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1.1 Enhanced Fluorescence 
Fluorescence has emerged as a useful tool for imaging and detection in medical and 
biological sciences due to its excellent sensitivity, wide availability of dye molecules, ease of 
application to broad classes of biomolecules, and robust detection instrumentation. Fluorescence 
is typically viewed as an electromagnetic and quantum mechanical phenomenon. When an 
excitation source is used to provide the necessary energy to excite a fluorescent molecule, the 
electrons within the molecule jump to an excitation state with a high vibrational energy. The 
fluorescent molecules have a short lifetime in this state and experience a loss in energy that leads 
to a fast decay of the electron to the lowest vibrational level of the excited state. Finally, when 
the electron relaxes back to the ground state, a Stokes-shifted photon is emitted. However, the 
major limitation of fluorescence is the strength of signals that can often limit visualization and 
quantification of low concentration analytes in numerous fluorescence-based assays. As a result, 
there is a need to either improve the fluorescent signal output or lower the background noise. 
In most conventional applications involving fluorescence imaging, the fluorescent dyes 
are used in a bulk context. The local environment of the molecules, thus, has no influence on the 
photonic properties of a fluorescent molecule. However, the improvements in lithographic 
techniques over the last two decades have made possible the ability to pattern nanoscale sub-
wavelength features into a variety of materials. There is a great deal of interest in techniques that 
can increase the sensitivity of fluorescent assays through the use of nanostructured optical 
surfaces that can locally enhance the electromagnetic fields that excite fluorescent emission and 
more efficiently couple fluorescent photons to a detection system.  Such approaches are broadly 
referred to as demonstrating EF. 
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Several approaches have been investigated for EF. Metal nanostructures can efficiently 
couple an external laser light source to substrate-immobilized fluorophores through surface 
plasmons that generate localized regions with enhanced electric field intensity [15-18]. When 
fluorescent molecules are placed close to the regions of these intensified electric fields, a 
subsequent enhancement in fluorescence emission by 10-100× has been reported. Despite the 
ability of metal-based nanostructures to generate evanescent fields, the application of plasmon-
based EF has been limited by the absorption of light at optical wavelengths (which limits 
resonant quality factor and thus the potential electric field enhancement factor) [15, 17], and by 
quenching of fluorescent molecules that are in close proximity to metal [19].  
An alternative approach to EF utilizes dielectric-based optical resonator surfaces, such as 
PCs. PC surfaces have demonstrated the ability to provide higher quality factor (Q~1000) optical 
resonances than surface plasmons [20, 21], a lack of quenching [21], and the ability to obtain 
enhancement factors as high as 7500× [22]. PC enhanced fluorescence (PCEF) has been 
performed upon plastic-based [23] and quartz-based [22] surfaces that can be inexpensively 
fabricated over large areas (i.e. entire 1×3 in2 microscope slides or 3×5 in2 microplates) by 
nanoreplica molding [24, 25] or nanoimprint lithography [26, 27]. A PC may be designed with 
multiple resonances that couple with both the wavelength of fluorescent excitation and the 
wavelength of fluorescent emission, so that the mechanisms of enhanced excitation (increased 
local electric field at the PC surface) and enhance extraction [20] (increased collection efficiency 
of emitted photons) can operate simultaneously with multiplicative effects [28, 29]. Microarray 
assays performed upon PC surfaces may be measured by conventional commercially available 
confocal laser scanners [29], but greater enhancement factors have been demonstrated using 
custom designed detection systems that utilize collimated laser illumination rather than focused 
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illumination [30].  PCEF has been applied to large DNA microarrays used for gene expression 
analysis [31], and to protein microarrays for detection of breast cancer biomarkers in serum [32, 
33].  
1.2 Next Generation Instrumentation for PC Biosensors 
PC biosensors have been identified as the ideal candidate to perform enhanced 
fluorescence in the context of a microarray. We therefore have identified a key ingredient, to 
achieve the ultimate goal of developing a highly multiplexed, sensitive and cost-effective means 
of cancer biomarker screening. However, a firm understanding of the interfacing between PC 
biosensors and their instrumentation is necessary to maximize the performance of this powerful 
technology.  To this end, a model for predicting EF performance of a PC in the context of a 
given set of instrument parameters as well as insights into instrument-specific device design is 
given in Chapter 2 [30].  Chapter 3 introduces a new label-free modality that is coupled with the 
fluorescence modality [34]. The PC properties are further exploited to introduce the new label-
free modality to allow for selective fluorescence enhancement as well as quality control for a 
protein microarray in Chapter 4 [33]. While detection limits are lowered, there is a still need for 
further improvement in this area. In Chapter 5 a novel line-scanning approach to PCEF is 
introduced [35]. The optimized objective-coupled PCEF line-scanning instrumentation is 
introduced and analyzed. Finally, concluding remarks and future outlook are presented in 
Chapter 6.     
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CHAPTER 2: PREDICTING PCEF PERFORMANCE 
2.1 Introduction 
PC surfaces provide a consistent and highly efficient platform for enhancement of 
fluorescence by exploiting their optical resonance characteristics to provide a heightened 
excitation field (resulting in a phenomenon called “enhanced excitation”) along with the ability 
to control the photonic dispersion which provides a powerful mechanism to redirect the emitted 
light into certain preferred directions, where it can be detected with greater efficiency (“enhanced 
extraction”). The simultaneous implementation of these two techniques has been shown to boost 
the radiation detected from quantum dots and fluorescent dye molecules by two orders of 
magnitude [20, 23, 28, 29]. PCEF has been performed with reasonable success by employing a 
confocal laser scanner that utilizes a focused laser beam [29, 36, 37]. However, owing to the 
angle selectivity of a PC biosensor, only a portion of the excitation energy from a focused beam 
can be coupled into the resonance mode and therefore contribute to enhanced fluorescence 
emission. In order to demonstrate improved PCEF performance, a collimated excitation scheme 
was employed, where the excitation beam matches the resonance angle of the target resonance 
mode [28]. Here, we select for a single excitation angle and attempt to image the entire PC 
surface. However, using this fixed-angle/fixed-wavelength excitation approach, only limited 
regions of a high-Q PCEF surface could be optimally excited.  While some parts of the PC were 
precisely “on-resonance” and therefore experienced the greatest enhancement factor, small 
variations in fabrication parameters or surface chemistry density would result in regions of the 
PC that were not optimally resonant with the excitation source, resulting in lower enhancement 
factor.  Fundamentally, this effect occurs because small changes in optical density on the PC 
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surface result in a shift in reflected wavelength (for a fixed illumination angle) – an effect that 
has been used effectively for PC-based label-free detection [38, 39].  When considering the use 
of PCEF surfaces for multiplexed assays using an array of immobilized biomolecule capture 
spots, this problem is especially critical because the optical density associated with the capture 
molecules substantially modifies the resonant conditions on the PCEF surface.  This 
phenomenon results in a situation in which the conditions for optimal enhanced excitation can be 
substantially different from spot to spot within a microarray. 
In this chapter, a previously characterized theoretical basis for these findings [30] is 
described by employing rigorous coupled wave analysis (RCWA). The RCWA helps to visualize 
the dependence of the resonant fields in a PC on the degree of collimation of the excitation laser 
light. Furthermore, a numerical scheme is presented to evaluate the field enhancement factor of 
PC biosensor surfaces.   
The design of a PC biosensor requires knowledge of how the material and structural 
properties of the device ultimately dictate EF performance.  While the relationship between 
physical sensor properties and the characteristics of the reflection spectra has been previously 
characterized [37], the focus here is on the degree of collimation, its impact on the resonant 
mode electric field distribution and the ultimate EF performance of a PC in the context of a 
particular system.  Consideration of the electric field profiles based on the illumination source 
used is a good guide for optimization of the photonic crystal structural parameters. 
2.2 Coupling of PC Sensor and Excitation Light 
The PC is a periodic arrangement of dielectric materials with sub-wavelength period, 
where the device reflects ~100% of the incident light at a specific wavelength and a specific 
angle. The wavelength and angle that match the coupling condition are defined as the resonant 
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wavelength (λr) and the resonant angle (θr). When the coupling conditions are satisfied, the 
resonant mode confined near the sensor surface is excited, and exhibits amplified field intensity, 
which enhances the fluorescent dye emission immobilized within a 200 nm region above the PC 
surface [21]. Unlike evanescent coupled optical micro- or nano-resonators [16, 40], which 
require highly precise position control, input light is coupled into PC resonator mode via angle 
and wavelength control. When most of the excitation beam is coupled into resonant mode, the 
near field strength becomes strong and consequently the PC sensor provides fluorescence 
enhancement. However, in the case of weak coupling, the PC enhancement effect is substantially 
diminished. A laser (He-Ne, λ=632.8 nm) is used to excite a specific fluorophore in the study. 
Therefore, the resonant wavelength of the PC surface was designed to overlap with the laser 
emission wavelength by tuning the angle of incidence.     
2.2.1 Photonic crystal sensor design 
Figure 2.1 shows a schematic model of the PC structure, which is comprised of a quartz 
substrate with the top surface etched to provide a periodic refractive index modulation. On top of 
the grating, a high refractive index thin film of titanium oxide (TiO2) is deposited as a wave 
guidance layer. The introduced periodic modulation allows for phase-matching of an external 
incident beam into leaky resonant modes that can be re-radiated into free space [20, 37]. The λr, 
θr, and bandwidth of the resonant mode can be controlled through proper selection of the grating 
period (Λ), grating depth (d), and thickness of the high index layer (t) depicted in Figure 2.1 [41]. 
The goal of designing the PC surface for fluorescence enhancement is to produce a 
strongly enhanced near field.  A high Q-factor (i.e. narrow bandwidth) PC structure is desirable 
to improve near field intensity [21].  In a 1D PC structure, the major contributor to energy loss is 
out-of-plane scattering by the grating structure. To improve cavity Q-factor and to enhance near 
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field intensity, a PC structure with smaller index modulation strength is desirable. Shallower 
grating depth reduces the out of surface coupling and significantly improves Q-factor. To 
examine the relationship between Q-factor and grating depth, an RCWA software package 
(Diffract MOD, RSOFT Design) was used to calculate the transmission efficiency as a function 
of illumination angle. An incident beam of λr and θr can be coupled into a resonant mode, 
resulting in a dip in the transmission efficiency, as measured in the far field. PC structures with 
three different grating depths (15 nm, 30 nm, and 100 nm) were studied. For all three PC 
structures, the grating period is Λ=400 nm while the TiO2 thickness was selected to maintain a 
resonant angle of 10° at a resonant wavelength of 633 nm (tTiO = 155 nm, 158 nm and 185 nm).  
The angle transmission spectra are shown in Figure 2.2. As expected, using shallower grating 
depth increases the Q-factor. However, as the Q-factor increases, the coupling condition 
becomes more stringent. For example, the angle tolerance of a d=100 nm grating is 0.76°, but the 
angle acceptable range of a d=15 nm grating is only 0.06°. In order to fully utilize the field 
enhancement capability of high Q-factor PC surfaces, the illumination must be well collimated.   
2.2.2 Resonant field distribution for diverged beam excitation  
Unfocused laser beams are highly collimated, but exhibit divergence that results in 
incident angle components with a Gaussian distribution around normal.  It is particularly 
important to note that commercially available fluorescence laser scanners use a focused laser 
beam [42-44]. As we move towards higher Q-factors for PCEF, the angle tolerance for exciting a 
resonant mode decreases.  Therefore, it is important to consider the beam divergence of the 
excitation light for optimal performance.  
Here we develop a calculation scheme to quantify how beam divergence affects the 
enhancement factor. A commercially available rigorous coupled wave analysis (RCWA) solver 
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(RSoft DiffractMod) can only output the field distribution in a PC that is excited by a plane 
wave. To simulate real laser excitation conditions, an analytical approach is combined with 
RCWA to provide field intensity distribution for a PC surface illuminated by any diverging 
beam.  
The total near field amplitude distribution 𝑬 𝑥, 𝑧   is averaged for field distribution at a 
specific angle 𝜃!  (j is an integer number from 0 to n) weighted by the intensity of the excitation 
beam 𝐼 𝜃!  . The field distribution at an individual angle, 𝑬!! 𝑥, 𝑧 , is calculated using RCWA. 
The expression of 𝑬 𝑥, 𝑧  is given by 
𝑬 𝒙, 𝒛 =    𝑰 𝜽𝒋 𝑬𝜽𝒋 𝒙, 𝒛𝒏𝒋!𝟎 .     (2.1) 
The spatial intensity distribution of a Gaussian beam propagating along the z-axis is 
given by 
𝐼 𝑥, 𝑧 =    𝐼! !!!(!) ! 𝑒! !!!!! ! ,     (2.2) 
where  𝑤! and 𝑤(𝑧) represent the minimum spot size and spot size at z, respectively [45]. 
In order to find the intensity distribution in terms of angle, the spatial distribution 
function is transformed into k-space governed by 𝐼 𝑥, 𝑧 ↔ 𝐼 𝜃, 𝑧   . The expression of the angle 
dependent intensity distribution function is 
𝐼 𝜃 =    𝐼! !! !!!! ! 𝑒!!! !! !"#! !!! !! .    (2.3) 
 
After focusing by a lens with a focal length f, the angle intensity distribution is given by 
  𝐼 𝜃 = 𝐼!!𝑒!!! !! !"#!!"! !,      (2.4) 
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where 𝐼!! =    !! !"!  and L represents the diameter of the laser beam.  In the case of a beam 
illuminating at the resonant angle, θr, Equation (2.4) can be written as  
  𝐼 𝜃 − 𝜃! = 𝐼!!𝑒!!! !! !!!!!! !"#! !!!! ,    (2.5) 
where F = f/L.  Substituting Equation (2.5) into Equation (2.1), the averaged field amplitude is 
given by   𝑬 𝑥, 𝑧 =    𝐼 𝜃! − 𝜃! 𝑬!! 𝑥, 𝑧!!!! .   (2.6) 
 
2.2.3 Simulation of field enhancement factor  
Using the developed numerical methods, we evaluated the field enhancement factor for 
the PC structures.  Since the resonant angle of the PC surfaces is designed for an incident angle 
of θ=10°, the RCWA was used to calculate field distributions in one period of the PC for 
0°<θ<20° with increments of 0.01°.  The illumination intensity at a particular angle (θj) is 
calculated using Equation (2.5) and multiplied with the field amplitude distribution, 𝑬!! 𝑥, 𝑧 , 
which was simulated using RCWA.  The averaged field intensity was found by taking the square 
of 𝑬 𝑥, 𝑧 .  Since the PC enhancement is a near field effect that is localized to the vicinity of 
sensor surface, only the field intensity within a 50 nm region above the surface is counted.  The 
ratio of the averaged field intensity as compared to the intensity on a reference glass slide is 
defined as the enhancement factor.  Assuming a laser spot with 1 mm diameter, the divergence of 
the beam after focusing can be altered using a lens with different focal lengths.  In the 
simulation, we consider the laser beam with divergence between 3.3° and 0.00033°.  As shown 
in Figure 2.3, when the excitation beam is highly diverging, the enhancement factor of a low Q-
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factor PC is higher than that of the high Q-factor PC.  However, the high Q-factor PC exhibits an 
enhancement factor of 263x if the excitation beam becomes more collimated.  An excitation 
beam with angle of divergence beyond 0.005° can be fully coupled into the resonance.  An 
excessively collimated beam will not result in a better enhancement factor once the coupling 
condition is met.   
To further illustrate the field enhancement effect, the averaged near field intensities of 
gratings with depth d=15 nm were calculated and compared in Figure 2.4 for three exemplary 
excitation beams with divergence of 11.46°, 0.1146°, and 0.01146°.  We investigate the effect of 
variations in excitation beam divergence on near field strength. In Figure 2.4, the field 
distribution in a single period of the PC structure is plotted at the resonant wavelength. The white 
contour highlights the surface of the grating substrate and the top of the PC surface. Figure 2.4(a) 
demonstrates the field intensity distribution at laser beam divergence of 11.46°.  Compared to the 
mode profile given in Figure 2.4(a), the near field shown in Figure 2.4(b) is ~60 times stronger 
when the excitation beam is less divergent (0.1146°).  For the case of least divergence shown in 
Figure 2.4(c), the field intensity is highest (~507 times higher than the least divergent case!).  
This example illustrates that using a highly collimated excitation source is critical to achieving 
the greatest enhanced near field.  
2.3 Enhanced Fluorescence Instrumentation 
Two different types of fluorescence detection systems were studied for PCEF: a 
commercially available microarray laser scanner and a modified fluorescence microscope that is 
specifically designed for PCEF.   
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The apparatus of the microarray laser scanner (LS Reloaded, Tecan Inc.) is shown in 
Figure 2.5(a). This system uses a focused laser beam (beam divergence ~ 2.5°) as the excitation 
source and a photomultiplier tube (PMT) as the fluorescence signal detector.  In order to form an 
image, the substrate is scanned and the fluorescence signal intensity for each pixel is acquired.   
The apparatus of the custom-built fluorescent detection system, which is referred to as the PC 
enhanced fluorescence microscope (PCEFM), is shown in Figure 2.5(b).  In the PCEFM system, 
the fluorescent sample is imaged by an electron-multiplying charge-coupled device (EMCCD, 
Hamamatsu Inc.) via a 4×-microscope objective (numerical aperture N.A.= 0.1). Unlike the 
confocal laser scanner, the PCEFM works in the imaging mode, which significantly improves the 
measurement throughput.  For both systems, a HeNe laser (λ = 632.8 nm) is used as an excitation 
light source, and a bandpass filter is placed in front of the detectors to reject excitation laser 
light. 
The microarray laser scanner uses a lens with a high numerical aperture (NA) to focus the 
laser beam onto the sample and collects the fluorescence signal resulting from this excitation. 
Due to the focusing effect, the illumination laser beam angle spans from 0° to 30°.  As a result, 
only a small portion of the excitation energy can be coupled into the resonant mode of the PC 
surface, thus compromising the enhancement performance of the PC.  For the PC surface with 
Q≈300, the coupling efficiency is less than 20%. As discussed above, in order to take full 
advantage of a PC and accomplish high enhancement of the fluorescence signal, it is critical to 
achieve a good coupling efficiency between the excitation laser beam and the PC surface. The 
PCEFM setup is designed specifically to achieve this and utilizes collimated illumination for this 
purpose.  As shown in Figure 2.5(b), the output of the HeNe laser is expanded to produce a beam 
with diameter of 20 mm and divergence of 0.037° using a beam expander. In order to accurately 
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control the angle of incidence, the PCEFM system utilizes a high-precision angle-tuning gimbal-
mounted mirror that is itself mounted on a motorized linear stage that moves as the mirror 
rotates.  The movement of this linear stage compensates for the beam shift due to incident angle 
variation and thereby ensures a fixed illumination area. The angle tuning resolution of this 
configuration is 0.005°, enabling one to test PC devices with angle bandwidth as narrow as 
0.01°. A coupling efficiency of 98% has been achieved using this system with a PC surface with 
angle bandwidth of 0.3°.   
2.4 Results 
The PC sensor used in this work was fabricated using nano-imprint lithography (NIL) 
[26, 27]. The detailed fabrication procedure has been fully described in a previous publication 
[22]. The fabricated PC structure has a period of Λ=400 nm, duty cycle of 50%, and grating 
depth of d=40 nm. As a high index layer, 130 nm of TiO2 was coated by RF-sputtering. 
Illuminated by a HeNe laser at λ=632.8 nm, this PC exhibits resonance at an angle of θ=10°. The 
coupling between the PC resonant mode and laser beam with different degrees of divergence was 
investigated.  The enhancement capability of the PC was compared between the confocal laser 
scanner and the PCEFM.   
2.4.1 Transmission spectrum 
In order to show the effect of laser beam divergence on the coupling between the PC and 
excitation light, we measured the transmission spectrum using focused and non-focused beams 
as illumination sources. To measure the transmission spectrum in terms of angle, the sample was 
illuminated by a He-Ne laser and the transmitted light power was monitored by a silicon photo-
detector while the angle of incidence was scanned around the resonant angle (9° to 11.5°).  Low 
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transmission (high reflection) efficiency indicates good coupling of incident light into the 
resonant mode of the PC. The divergence of the incident laser beam was varied using lenses of 
different focal lengths. Without a focusing lens, the divergence angle is 0.081°; using lenses with 
focal lengths of 125 mm and 60 mm, the beam divergences are 0.564° and 1.175°, respectively. 
As shown in Figure 2.6, the measured transmission spectra were compared for the collimated and 
non-collimated illumination. Using a collimated laser beam, the transmission efficiency was 5% 
at resonant angle with angle full width at half maximum of 0.37°.  The transmission efficiency 
increases to 39% and 51% when the laser beam is focused by lenses with 125 mm and 60 mm 
focal lengths, respectively. Due to the broadening of incidence angle, a lower percentage of 
excitation energy is coupled into resonance, and transmission efficiency becomes higher. With 
regard to PC enhanced fluorescence, the diverged beam results in only a portion of the excitation 
energy being amplified by the PC resonance, which diminishes the fluorescence enhancement 
capability of the PC sensor. 
2.4.2 Enhanced fluorescence intensity 
Having established a clear relationship between degree of collimation of incident light 
and coupling efficiency with a PC, fluorescence measurements were performed to 
experimentally correlate the influence of degree of collimation of incident light with the extent of 
fluorescence enhancement. The microarray laser scanner and the PCEFM discussed in Chapter 3 
were used, to represent cases for focused and collimated light. The signal enhancement factor for 
the on-resonance case with respect to the off-resonance case was measured over a range of 
angles around the resonance angle. This is shown in Figure 2.7.  
The collimated light gave a signal enhancement factor almost 7x higher than the case for 
the focused light. This can be easily explained as a direct consequence of the higher magnitude 
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of surface localized electric field intensity that interacts with fluorophores immobilized on the 
surface of the PC.  
Another interesting observation was that the signal enhancement is much more sensitive 
to the proximity to the resonance angle for collimated excitation (FWHMθ< 0.4°) than for 
focused excitation (peak FWHMθ> 1.5°). This can be explained as a consequence of the 
sensitivity of the coupling efficiency of the PC to change in excitation angle for collimated light. 
Thus, for the PCEFM a small deviation from the resonance condition will result in a large drop 
in the surface localized electric field intensity, ultimately leading to lower enhancement in 
fluorescence intensity. For the case of focused light, since the incident beam consists of a spread 
of angles, over a fairly large range there will always be some light present in the resonant angle 
range. Thus, even though the coupling will never be as efficient and the electric field intensities 
will never reach high values, the fluorescence enhancement will have a much greater angle 
tolerance. Thus the degree of collimation of the excitation light  (which influences the coupling 
efficiency of the PC as described in the previous section) is the ultimate determining factor for 
the degree of enhancement. The sensitivity of the degree of enhancement to the proximity to the 
resonance angle has far-reaching implications for performing multiplexed assays on a PC 
surface.  
We performed a study to analyze the total enhancement of the PC on-resonance 
compared to unpatterned glass. Figure 2.8 shows a bar graph plot for the signal enhancement as 
measured on the PCEFM and the confocal laser scanner. The plot shows a very high signal 
enhancement for the on-resonance case compared to the off-resonance case (169× for PCEFM, 
and 15× for the laser scanner), which is due to the enhanced excitation effect. The off-resonance 
case for the PC also has a higher signal as compared to a glass slide (~4× for the PCEFM and 
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~2× for the laser scanner). This is a result of the PC enhanced extraction effect [20]. In this case, 
emitted photons, which would ordinarily exit the surface distributed uniformly in all directions, 
are spatially biased away from the PC surface at a (approximately) normal angle, so they may be 
gathered more efficiently by the detection optics.  
The combination of the two enhancement effects provides a net signal enhancement 
(compared to unpatterned glass) of ~677× using the PCEFM and ~29× using the laser scanner.  
2.4.3 Angle-scanned image optimization 
Having established the superior performance of a PC under collimated conditions and the 
promise of high enhancement offered by the PCEFM, it is necessary to provide a uniform 
enhancement effect over substantial surface areas, such as those used for protein microarrays or 
DNA microarrays that are comprised of hundreds or thousands of capture spots.  Because the 
enhancement factor is highly sensitive to the angle of incidence for a collimated beam (Figure 
2.7), small variations in the PC surface resonant coupling angle caused by non-uniformities in 
the PC structure (for example, the TiO2 layer thickness) and the density of surface 
functionalization layers will result in substantial variations in fluorescent intensity if a fixed 
incident angle is used to scan the entire device.  This problem is further complicated by the 
variable density of immobilized capture molecules, such as DNA or antibodies, which are 
deposited as arrays of spots on the PC surface.  Capture molecules are typically deposited with 
high density, and therefore result in a substantially lower PC coupling angle compared to the 
regions of the surface between capture spots.  There is thus no single incident angle that can be 
used to optimally couple a laser to every region of a PC surface. 
In order retain the benefits of signal enhancement while still performing fast, high-
throughput measurements, we developed a methodology to account for the variation in the 
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resonant coupling angle across the device. Rather than gathering fluorescent output images with 
the PCEFM using a single incident angle, we capture a sequence of fluorescence images over a 
range of angles that always includes the resonance angle. Software is used to compare the images 
taken at each angle, and to select the maximum intensity of every pixel over the scanning range.  
Because the maximum intensity for any pixel will always be generated when the incident angle 
matches the optimal resonant condition, a new image can be constructed using the maximum 
intensity angle for each pixel.  
To demonstrate the angle-scanning method, a 3×3 array of Poly(Lys, Phe) conjugated 
with Alexa-647 (Invitrogen) was spotted at a concentration of 9.9 µg/ml onto the 1×3 in2 PC 
surface by a piezoelectric dispenser (Piezorray, Perkin Elmer) with a center-to-center separation 
of 500 µm and a spot radius of ~200 µm. Prior to spotting, the PC surface was pre-cleaned with 
O2 plasma for 3 min and then cleaned by sonication in acetone, isopropanol and deionized (DI) 
water followed by drying under a nitrogen stream. After spotting, the PC was incubated for 24 
hours in a sealed container. The spot densities were selected so as to give an approximate shift of 
-0.2° in the PC coupling condition.  
Selecting a single incident angle of θ=10°, the PCEFM gathered the image shown in 
Figure 2.9a.  Using a 4× microscope objective, a single fluorescent image has a field of view of 
~2×2 mm2.  An automated motion stage enables capture of fluorescent images from adjacent 
regions, and concatenation of images results in a fluorescent image of the entire slide, using a 
total scanning time of 24 seconds.  Nominally, each spot in the array is identical, but the 
fluorescent intensity shows the effects of non-optimal laser coupling to the PC resonance in 
several regions of the chip, resulting in a coefficient of variability of CV=51% for the on-spot 
intensity. 
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Figure 2.9(b) is a fluorescence image of the same slide as in Figure 2.9(a) with the image 
constructed by the new methodology.  For each imaged region, a sequence of fluorescence 
intensity images is gathered from 9.5°<θ<10.5° in 0.1° increments, for a total of 11 images per 
frame.  By gathering the additional images, the scanning time for the entire 1x3 in2 area 
increased to 48 sec.  The maximum-pixel selection and composite image-processing algorithm 
runs in 60 sec.  As a result of the new method, the spot CV is reduced to 17.9%.  This level of 
spot-to-spot variability is consistent with what is typically obtained for fluorescent images of 
spot intensities on glass surfaces (data not shown), and therefore represents variability due to the 
spots themselves, rather than variability in the detection method.  Using the angle scanning 
approach, we observe a consistently high enhancement factor across the entire PC area. 
2.5 Conclusion 
We have discussed a study of PCEF for illumination with laser beams having different 
degrees of divergence. By use of an imaging system that enables angle-tunable collimated 
illumination of the PC surface, we established improved performance for PC when subjected to 
collimated excitation as compared to focused excitation in a confocal laser scanner, 
demonstrating raw signal enhancement of 677×. The signal enhancement is accompanied by an 
extreme sensitivity to the angle of excitation. The resulting problem is variability when 
attempting to utilize the PCEFM for high throughput measurements, such as those used in DNA 
microarrays or protein microarrays. The angle-scanning method developed to address this issue 
allows optimal coupling to every pixel in a PC-based fluorescent image, and thus achieves a 
uniformly high enhancement factor over large surface areas. This is promising step toward 
developing PCEF instrumentation. 
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 2.6 Figures 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Schematic diagram of a PC sensor. The grating structure is etched into a quartz 
substrate with period and duty cycle of 400 nm and 50%, respectively.  
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Figure 2.2 Simulated transmission spectra of three different PC designs.  The PC gratings have 
depths of 15 nm, 30 nm, and 100 nm, respectively. The period of the gratings is 400 nm and the 
TiO2 thicknesses are 155 nm, 158 nm, and 185 nm, respectively, to maintain a constant angle of 
resonant coupling for a wavelength of λ=632.8 nm.   
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Figure 2.3 Simulated local field enhancement factors in terms of angle divergence of the 
excitation laser beam for PC substrates with different Q-factors.  
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Figure 2.4 Simulated local field enhancement factor in terms of angle divergence of the 
excitation laser beam for PC surfaces with different angle of divergence for a 15 nm depth 
grating.  
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Figure 2.5 (a) Schematic diagram of optical setup of the confocal laser scanner and (b) schematic 
drawing of PC enhanced fluorescence microscope.   
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Figure 2.6 Transmission spectrum of a PC enhancement substrate where the resonant angle is 
around 10°.  The illumination spot has divergence of 1.175°, 0.564°, and 0.081°.   
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Figure 2.7 Comparison of the fluorescence intensity as a function of excitation angle measured 
using the PCEF microscope and the confocal laser scanner.  
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Figure 2.8 Comparison of the fluorescence enhancement using the PCEF microscope and the 
confocal laser scanner. The fluorescence signal enhancement for the PC on-resonance compared 
to the off-resonance case is attributed to the “enhanced excitation” property of the PC. The 
fluorescence signal enhancement for the PC off-resonance compared to unpatterned glass is 
attributed to the “enhanced extraction” property of the PC. The total enhancement is the ratio of 
the fluorescence signal for the PC on-resonance to the unpatterned glass. 
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Figure 2.9 Intensity profile as a function of distance for a line of fluorescent image pixels 
profiling spots of Alexa-647 conjugated PPL for the PC (a) using a fixed excitation angle at 10° 
and (b) with the fluorescence intensity scanned at 11 angles near the resonance angle. The 
scanned images are shown in insets.  
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CHAPTER 3: SPATIALLY SELECTIVE PCEF 
3.1 Introduction 
PC optical resonances have also been exploited as a platform for label-free (LF) 
detection. The incorporation of biomolecules into the evanescent field region of the PC results in 
a positive shift of the resonant wavelength (for a fixed incident angle) [24, 39, 46] due to the 
increased dielectric permittivity of biomolecules with respect to water.  An alternative method 
for LF detection on a PC surface that allows high-resolution imaging of surface-based 
biomolecular interactions is to measure a shift in the resonant coupling angle, when illuminating 
the PC surface with a fixed wavelength from a laser [28, 47]. A microscope-based detection 
instrument for label-free imaging the density of immobilized microarray capture spots [32, 47] 
and cells [48] has been demonstrated by detecting shifts in the angle of minimum transmission 
(AMT) as a function of position upon a PC surface with ~3×3 µm2 pixel size.  
The fact that the resonant coupling conditions of a PC shift due to the presence of 
immobilized biomolecules poses a unique challenge and opportunity for fully exploiting PCEF.  
Obtaining the greatest possible enhancement factor for enhanced excitation requires that the PC 
be illuminated at the precise wavelength/angle combination for optimal resonant coupling.  As 
discussed in Chapter 2, while high quality-factor PC resonances yield the greatest enhancement 
factor, they also have the most stringent coupling condition.  For example, the illumination of a 
PC surface at the optimum coupling angle/wavelength results in a ~100× enhancement factor, 
while a θ=0.4° incident angle deviation reduces the enhancement to only 10×, and a deviation of 
θ=1.2° completely eliminates the enhancement.  The regions of a PC surface with a high density 
of immobilized capture molecules, such as the capture spots of a microarray, have very different 
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coupling conditions than the regions of a PC surface between the capture spots.  Therefore, it is 
possible to selectively obtain a large enhancement factor from the capture spot regions of a 
microarray by illuminating them in an optimal “on-resonance” condition, while at the same time 
illuminating the regions of a microarray between the capture spots in an “off-resonance” 
condition.  In this way, the fluorescent signal emitted from active assay regions of the surface 
can be maximized, while the background fluorescence between spots can be minimized, thereby 
substantially improving image contrast.  The problem of obtaining optimal and equal excitation 
conditions for an entire microarray is further exacerbated by the fact that the biomolecular 
density of immobilized capture spots is not completely uniform due to a variety of factors that 
include spot buffer concentration variability, capture spot density non-uniformity, surface 
chemistry non-uniformity, capture molecule binding affinity variation, analyte molecular weight, 
and analyte concentration in the test sample.  As a result, no two spots in a microarray are 
guaranteed to have the same optimal resonant coupling condition, and optimally resonant 
conditions can even vary within a single spot. 
In this chapter, a previously introduced method for combining PCEF and label-free 
modalities is discussed in great detail [34]. We will discuss a detection instrument and an image 
processing approach that takes full advantage of the optimally available enhancement factor for a 
PCEF surface for every location of a PC surface.  The method presented utilizes a label-free 
image of the microarray capture spots to identify the locations of an array surface that are within 
a capture spot, and to differentiate “on-spot” regions from those that are “between spots.”  To 
obtain optimum on-resonance coupling for the entire microarray in the presence of differences in 
immobilized spot density, a series of fluorescent images are rapidly gathered using a range of 
incident angles separated by small angle increments. An image processing algorithm is applied 
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that generates a composite fluorescent image in which the maximum fluorescent intensity is 
selected for on-spot regions on a pixel-by-pixel basis, while between-spot regions are displayed 
using data collected in an off-resonance condition.  The method is demonstrated to substantially 
improve the contrast of microarray images while maximizing the uniformity of the fluorescent 
image through the application of a uniform enhancement factor. The method provides substantial 
gains in signal to noise for the cases where assays are specific and background fluorescence is 
low. However, in most biological assays, issues of high substrate autofluorescence, background 
fluorescence from blocking reagents and non-specific binding can minimize the gains in signal-
to-noise ratio (SNR) provided by the PC’s enhancement capabilities. In such situations, selective 
enhancement is desirable to maximize image contrast and nullify the effects of non-specific 
binding.   
3.2 PC Structure and Dual Mode LF-EF Detection Instrument  
3.2.1 Photonic crystal device structure fabricated by nanoimprint lithography 
A schematic diagram of the PC surface is shown in Figure 3.1(a).  The sub-wavelength 
grating is fabricated on a quartz substrate with refractive index of n=1.46.  On top of the grating, 
a layer of high refractive index (n=2.35) TiO2 dielectric material is deposited as a light 
confinement layer that supports establishment of optical resonances.  The electrical field 
associated with the resonant mode extends from the device surface into the surrounding medium. 
The wavelength and angle of incidence of the resonant modes is determined by the geometry of 
the structure.  In this study, the PC structure was designed to exhibit strong optical resonances at 
two specific laser wavelengths, λ=633 nm and λ=690 nm.  As described in Section 3.2.2, the 
λ=633 nm resonance will be used for fluorescence excitation, while the λ=690 resonance will be 
used for label-free detection.  To efficiently couple both lasers with the PC, the geometric 
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parameters were determined by rigorous coupled wave analysis (Diffract Mod, Rsoft Design) 
with a grating period of Λ=400 nm, grating depth of d=50 nm, 30% duty cycle, and t=140 nm 
thick TiO2 coating.  The PC surface was fabricated over microscope-slide-sized quartz substrate 
(25×75 mm) by nanoimprint lithography as described in a previous publication [22].  An SEM 
image of a cross section of the PC surface is presented in Figure 3.1(b). 
In order to predict the resonance modes, the transmission efficiency of the PC structure 
was simulated in the wavelength range of λ=600-800 nm and the incident angle was varied from 
0°<θ<20°. The device resonance condition is identified by measuring the dip in the transmission 
efficiency when the PC is subjected to broadband illumination.  By plotting the transmission 
efficiency as a function of wavelength and incident angle, Figure 3.2 describes the photonic band 
diagram of the PC surface shown in Figure 3.1. The photonic band diagram elucidates the 
conditions to be used for LF measurement and the optimal conditions for PCEF.  For example, 
fluorescent excitation from a laser with λ=633 nm needs to be coupled at an incident angle of θ 
=10.7°.  This mode was chosen for fluorescence imaging since the target dye molecules 
(Cyanine-5 and LD-700) absorb strongly at this wavelength.  The other resonant mode at λ=690 
nm requires a near-normal incident angle of θ=0.7° for label-free detection.  
3.2.2 Apparatus for dual-mode LF-EF detection  
Figure 3.3 shows a schematic of the PC enhanced microscope (PCEM) that combines the 
label-free and enhanced fluorescence imaging capabilities using a PC substrate.  Two lasers are 
used in the system.  A 35 mW HeNe laser (CV Melles Griot) at λ=632.8 nm was chosen to 
function as the excitation light source for fluorescence imaging and a 50 mW AlGaAs 
semiconductor diode laser (Crystal Laser) emitting at λ=690 nm was used for the label-free 
modality.  A dichroic mirror (Semrock) is used to combine the two laser beams along a common 
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path.  The setup controls the angle of incidence for excitation light by employing a computer 
controlled rotational mirror and a linear translation stage beneath the PC. The incident angle can 
be tuned between θ=0° and 20° in increments as low as θ=0.005°. Both imaging modalities 
require the incident angle to be tuned.  In the label-free mode, we tune the incident angle from 
θ=0° to 3° to cover the resonance angles over the entire field of view. For enhanced fluorescence 
imaging, the angle of incidence is scanned between θ=10° and 13°. For each modality, assuming 
we capture a sequence of 400 images at increments of 0.01°, the time required to capture each 
frame is approximately 12 seconds. This translates to a time of 9 minutes to scan a PC-
microscope slide with a total of 48 frames of 2×2 mm2. The PC is held on a computer controlled 
x-y translation stage that allows the entire PC surface to be imaged in a tiled fashion, with 
adjacent fields of view compiled together to create an image of the entire PC.  
The imaging collection part of the setup was built upon an Olympus BX-51 upright 
microscope with a 4×-objective (N.A.=0.1, Olympus PLAN N) and an electron multiplying CCD 
camera (9100-13, Hamamatsu). For fluorescence imaging, a bandpass emission filter (Semrock) 
is used.  The filter blocks the light for the laser with λ=633 nm (fluorescence excitation) with 
optical density of 7 but transmits the light from the λ=690 nm laser (label-free imaging). A single 
field of view is ~2×2 mm2. 
The implementation of the PCEM is ideal for combined enhanced fluorescence and label-
free imaging owing to several important features. First, it uses a common beam-path for both 
imaging modes, facilitating acquisition of spatially registered images of fluorescence and 
surface-bound molecular density. Second, the use of a λ=690 nm laser for label-free detection 
allows for rapid sequential image capture while eliminating the potential for photobleaching of 
fluorescent dye during label-free imaging. Third, the use of a charge-coupled device (CCD) 
	  	  
36	  
rather than laser scanning imaging simplifies the optical setup and enables large-area, high-
resolution and high-throughput analysis. Fourth, a high-resolution motorized gimbal-mounted 
mirror and beam-expanded laser provide efficient and selective light coupling to the PC, which is 
especially crucial for the narrow resonances that provide optimal fluorescence enhancement and 
sensitive label-free detection. Lastly, other imaging techniques available on the microscope, such 
as reflected brightfield and differential interference contrast, can be overlaid with enhanced 
fluorescence and label-free images.  
3.3.  Selective Fluorescence Enhancement on PC Substrate  
It has been demonstrated that the PC surface has the capability to enhance fluorescence 
emission from dye molecules located within the evanescent field of the PC structure [21]. While 
the emission from fluorescent-tagged molecules is enhanced, the same resonant near field will 
also enhance the output of any other fluorescent emitter that resides within the evanescent field, 
resulting in elevated “background” fluorescent signals.  The background signals associated with 
the PC structure can include fluorescence from tagged molecules attached by nonspecific 
binding, surface chemistry layers, the TiO2, and the substrate. This background coexists with the 
fluorescence emission from molecules that we wish to detect, resulting in loss of contrast.  
Generally, capture molecules (single strand DNA or antibodies) are applied as an array of 
“spots” (50-500 µm diameter) in which the fluorescent signal from tagged analyte molecules are 
measured.  We are therefore most interested in the signal obtained within the spot regions, and 
not interested in the fluorescent intensity in regions between the spot regions. This section 
describes the scheme applied to avoid fluorescent enhancement in regions between capture spots.  
The method relies on the recognition of an area of interest (AOI) via label-free imaging detection 
of the capture molecule spots deposited on the PC surface.  The label-free detection relies on 
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monitoring changes in the optical resonance angle of the PC as capture molecules are attached to 
the PC.  The area in which capture molecule spots are present is defined as the AOI and 
identified as the region that requires fluorescence signal enhancement.   
As an illustration of this approach, we used photolithography to create a high contrast 
pattern (in the image of George Washington) on the PC surface with two distinct resonant 
coupling conditions via deposition of a 10 nm SiO2 thin film only in the transparent regions of 
the image. The SiO2 layer shifts the resonant angle of the PC by a small amount relative to 
regions without added SiO2.  After patterning, a uniform layer of fluorescent dyed polymer film 
is applied over the entire PC.  By differentiating two distinct regions (with SiO2 or without added 
SiO2), we demonstrate that it is possible to selectively obtain fluorescent enhancement from 
either region through proper adjustment of the illumination angle of the λ=633 nm laser.  
3.3.1 Label-free imaging using the PC 
In order to generate a label-free image of the deposited SiO2 pattern, we first captured a 
sequence of images of the PC illuminated by the λ=690 nm laser with the angle of incidence 
varying from θ=0° to 2°. The images are used to record changes in transmission intensity at each 
angle. The resonant angle is the designated AMT of incident light through the PC. This AMT is 
computed for each pixel in the image stack by fitting the transmission versus angle data with a 
polynomial function and finding the angle corresponding to the minima of the fitted curve [28]. 
The spatial distribution of AMT represents a label-free image of the SiO2 density, and is 
analogous to the density of deposited biomolecule capture spots.  
The resulting label-free image of the SiO2 pattern is shown in Figure 3.4(a). It can be 
seen that the resonant angle ranges from θ=1.07° to 1.65°.   The difference in the resonant angle 
between the two regions is θ≈0.35°.  Figure 3.4(b) shows the transmission spectra measured on 
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and off the pattern, demonstrating a clearly measurable change in the angle of resonance. As 
shown in Figure 3.4(c), the resonant angle can be used to generate a “mask” that bins each pixel 
into a region identified as with/without additional SiO2 based on selection of a resonant angle 
threshold.  In order to calculate the threshold angle θTA, we selected a background region known 
not to contain capture spots on the AMT image as our control. The average angle and the 
standard deviation in the angle were calculated for the control region. A threshold angle was 
determined to be three standard deviations above the average background angle. It is important 
to note that if the separation between the “on spot” and “between spot” regions is less than three 
standard deviations of the variation in the control region for that frame, this technique is not 
applicable. The fluorescence excitation laser illumination conditions can then be selected to be 
“on-resonance” with only one region for enhanced fluorescence, while the other regions is 
illuminated under “off-resonance” conditions.  This capability is shown in Figure 3.5, in which 
the entire PC is coated with a uniform fluorescent polymer thin film (~50 nm film of SU8 doped 
with LD-700 dye applied by spin-coating), but either region can be enhanced based on selection 
of the fluorescent illumination angle. 
To optimize image contrast for a selected region, we capture a sequence of fluorescence 
images over a range of angles to ensure that we always achieve the resonant coupling condition 
for each pixel somewhere within the range and thus the maximum possible fluorescence signal 
from each pixel.  To generate a selectively enhanced “signal” fluorescence image we choose the 
maximum fluorescence signal value for every pixel above the threshold and the minimum value 
for every pixel below the threshold.  To generate a selectively enhanced “background” 
fluorescence image we choose the minimum fluorescence signal value for every pixel above the 
threshold and a maximum value for every pixel below the threshold. Figures 3.5(c) and 3.5(d) 
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show the fluorescence images after the mask (shown in Figure 3.5(a) and 3.5(b)) was applied to 
the sequence of fluorescence images. We notice a clear enhancement in the contrast of our image 
showing the efficacy of the technique.  
Similar to this example, there is a distinct difference between the on-spot and between-
spot regions of a microarray that can be measured using label-free imaging of the capture spot 
density. The difference in AMT between on-spot and between-spot regions can be used to select 
a threshold that can be used to selectively enhance fluorescence from the regions of a microarray 
within a capture spot.  
3.4. Application to a Cytokine Immunoassay 
The developed fluorescence detection approach is especially useful for protein and DNA 
microarray applications that require highly concentrated capture proteins or oligonucleotide 
probes. One such application is the sandwich ELISA.  The sandwich ELISA in a microarray 
format is well suited for clinically relevant analyses [49, 50].  This is because the sandwich 
ELISA is the standard assay used in the clinic for analyzing low-abundance proteins in complex 
biological fluids such as blood.  Like the clinical assays, the ELISA microarray assays are 
exceptionally sensitive, being able to accurately quantify proteins down to the single-digit or 
sub-pg/ml concentrations [49]. The assay is performed by deposition of array of antibody capture 
spots upon a substrate (such as glass, or alternatively a PC), using several replicate spots per 
antibody to enable observation of experimental variability.  After a “blocking” step that covers 
the substrate surface with molecules that inhibit subsequent nonspecific binding, the chip is 
exposed to the test sample, providing opportunity for analyte molecules to bind with their 
corresponding capture antibodies [51, 52].  Biotin-linked secondary antibodies for each of the 
assays are combined and exposed to the chip as a mix, where they bind an unoccupied epitope of 
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the targeted captured antigen. The final assay step is introduction of fluorophore-labeled 
streptavidin that attaches only to the biotinylated detection antibodies.  Full details of the 
procedure have been published in several papers [32, 51, 53-57]. 
As an illustrative example of the application of our selective fluorescence amplification 
approach to a sandwich ELISA, an antibody microarray chip was prepared by immobilizing 
capture antibodies for the cancer biomarker TNF-α using a spotting buffer solution with a high 
concentration.  On a PC chip, the regions with immobilized capture antibodies exhibit large 
resonance shifts that are detected and quantified by the label-free imaging mode of PCEM.  By 
analyzing the recorded label-free image, the capture antibody spots are recognized and assigned 
as the AOIs to be selectively enhanced for fluorescence detection.  
In preparation for the assay, epoxysilane-based surface chemistry was applied to the PC 
surface by a vapor-phase deposition of 3-glycidoxypropyl-trimethoxysilane [58] in a vacuum 
oven.  The PC surface was divided into 6 separate regions by drawing ~2 mm wide hydrophobic 
barriers between arrays with a hydrophobic pen (Super HT Pap Pen, Research Products 
International Corp.). As an immobilized capture molecule, the antibody for TNF-α was diluted in 
phosphate buffered saline (PBS) to a concentration of 0.8 mg/ml and 9 replicate spots per assay 
were printed in each array on PC slides using a noncontact printer (Piezorray, Perkin Elmer). 
Following printing, the slides were incubated overnight in a humid chamber maintained at 4°C. 
The slides were then blocked in a solution of 1% casein (Bio-Rad) in PBS for 1 h at room 
temperature. To generate a dose-response curve, a four-fold dilution series of the TNF-α antigen 
(BioRad) in PBS for a total of six concentrations (1000 pg/ml, 250 pg/ml, 62.5 6g/ml 15.6 pg/ml, 
3.9 pg/ml and 0.97 pg/ml) was added onto the slide surface.  After overnight incubation at room 
temperature, the PC was washed in PBS-T, followed by incubation with biotinylated secondary 
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detection antibody for TNF-α at 200 ng/ml in PBS-T for 2 h. The PC was washed with PBS-T to 
remove excess secondary antibodies and was incubated in a solution of 1 µg/ml streptavidin-
Cyanine 5 (GE Healthcare) in PBS-T for 30 min. Finally, the slides were washed in PBS-T, and 
blow dried to remove standing liquid. 
To identify the capture spots on the PC, the slide was scanned using the PCEM in the 
label-free mode.  The incident angle of the λ=690 nm laser was scanned from θ=0° to 3° which 
covered the resonant angles of the both spot resonance and background resonance. The label-free 
image (AMT map) of the PC is shown in Figure 3.6(a).  The region spotted with capture 
antibody has resonant angle between θ=0.50° and 1.62°, while the resonant angle of the 
background area ranges from θ=1.05° to 1.75°. In order to discriminate the spots from 
background, we set the AMT threshold (from left to right in Figure 3.6(c)) as θTA=1.62°, 1.30°, 
1.05°, 1.10°, 1.00° and 1.20° respectively for each imaged field of view.  If a pixel on the label-
free image has an AMT value smaller than θTA, this pixel will be recognized as a pixel in the on-
spot region. As described in the previous example, the AMT threshold provides a criterion to 
generate a mask for the consequent fluorescence measurement. (It is important to note here that 
the threshold angle is determined by the relative position of the PC resonance peak at normal 
incidence with respect to the excitation wavelength of 690 nm. This peak position is altered to 
higher wavelength values by any alteration to the effective refractive index of the PC. In the 
previous example the position of the resonance peak at normal incidence was above 690 nm. 
Thus, adding extra SiO2 caused the peak to shift further away from 690 nm resulting in a larger 
resonance angle to achieve coupling in the regions with more SiO2. For the present case, the 
device used had a resonance peak, at normal incidence, below 690 nm. Therefore, the presence 
of additional material, TNF-α spots, resulted in a peak closer to 690 nm thereby needing a 
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smaller resonance angle to achieve coupling.) The fluorescence images were acquired with the 
λ=632.8 nm laser, for which the resonant angle of the PC lies between θ=9.75° -10.25°.  A series 
of 51 fluorescent images were recorded with excitation angle varied between θ=9.5° and 10.5°.  
At θ=10.0° (which is close to the resonant angle of the spotted area), the fluorescent image is 
shown in Figure 3.6(b).  While applying the pre-generated mask, only the signals from the 
spotted region were enhanced.  Figure 3.6(c) shows the selectively enhanced fluorescence image. 
Compared with Figure 3.6(b), the spot-to-spot signal intensity in Figure 3.6(c) is more uniform 
for any given frame and background signal is lower.     
To quantify the spot and slide background intensities, an image processing software 
package (ImageJ) was used. The average fluorescence intensity was measured from all nine spots 
for each concentration, and the standard deviation was calculated. The measured data for 
fluorescence detection with and without applying the label-free mask are compared in Figure 3.7. 
It is evident that the fluorescence signal measured at a single angle for the concentrations of 3.9 
pg/ml and 0.97 pg/ml are indistinguishable. However after applying the masked detection, the 
fluorescence signal measured at 0.97 pg/ml is distinctly different than that of the 3.9 pg/ml TNF-
α concentration. It can also be inferred that while the minimum detectable concentration for 
single-angle fluorescence detection is greater than 3.9 pg/ml, the masked detection method 
reduces the lowest detectable concentration below 0.97 pg/ml. 
3.5 Conclusion 
We demonstrated a scheme to selectively enhance fluorescence emission on a PC surface 
from regions that contain capture molecules, such as those used in DNA or protein microarrays.  
The approach is possible because the capture molecules, deposited with a high surface mass 
density, modify the resonant coupling condition that is used to obtain enhanced fluorescence.  
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Thus, on-spot and between-spot regions can be selectively illuminated under on-resonance or 
off-resonance conditions.  The label-free image of the capture spot density is quantified by 
generating a spatial map of the AMT from the PC surface, which is used to distinguish on-spot 
and between-spot regions using a user-defined AMT threshold.  To avoid photobleaching during 
the label-free imaging process, a longer wavelength laser excitation source was selected with 
photons of insufficient energy to excite fluorescence.  The photonic dispersion diagram was used 
to reveal the relationship between the incidence angle and wavelength of the excitation beam, 
and selection of incident angles for label-free imaging and fluorescent imaging.  During 
fluorescence measurement, a series of fluorescence images   are gathered over a small range of 
angles, assuring that every on-spot region is illuminated under optimal coupling conditions in 
order to maximize the fluorescent enhancement factor on a pixel-by-pixel basis.  A simple image 
processing approach is used to generate a composite fluorescent image from the angle-scanned 
individual images. 
The approach described in this chapter can be broadly applied to any surface-based 
fluorescence assay performed on a PC to improve image contrast, to reduce assay CV caused by 
myriad sources of spot-to-spot variability, and to lower limits of detection. However the 
applicability requires a relatively clean print distinction in order to work effectively. Thus the 
translatability of this technique to a multiplexed microarray may prove challenging. 
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3.6. Figures 
 
Figure 3.1 (a) Schematic diagram of the PC surface. The grating structure is patterned on a 
quartz substrate with period and duty cycle of 400 nm and 50%, respectively. (b) Cross sectional 
SEM image of the PC. (c) A photograph of a full 1×3 in2 PC device. 
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Figure 3.2 Simulated dispersion diagram for the PC structure of Figure 1. The plot shows 
minima in transmission efficiency (corresponding to on-resonant coupling) at λ=690 nm and 
λ=633 nm for particular angles of incidence.  
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Figure 3.3 Schematic diagram of the PCEM using λ=633 nm and λ=690 nm lasers. 
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Figure 3.4 (a) Label-free image of the PC with a pattern of deposited 10 nm SiO2 film. The 
image clearly highlights the variation in resonance angle in the transparent and opaque areas of 
the pattern. Our selection of a negative control region is highlighted with a white dashed box. (b) 
Transmission spectrum of the pattern showing the difference in angle of resonance (minima in 
transmission) for the areas with and without additional SiO2. More SiO2 gives a larger resonance 
angle. (c) Histogram showing the distribution of resonance angle versus the number of pixels 
used to make our selection of the threshold angle. The inset image shows the mask generated by 
using the threshold set by θTA = 1.28 °. The green region has a resonance angle above the 
threshold angle and the yellow region has a resonance angle below the threshold angle.  
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Figure 3.5 (a) Fluorescence images taken at single angle θ = 11.52 ° where the region with the 
SiO2 coating satisfies resonant condition. (b) Fluorescence images taken at single angles θ = 
11.9 ° where the region without SiO2 coating satisfies the resonant condition. (c) Selectively 
enhanced “signal” fluorescence image showing superior contrast to (a). (d) Selectively enhanced 
“background” fluorescence image showing superior contrast to (b). 
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Figure 3.6 TNF-α detection performed on a PC using a sandwich ELISA assay. The antigen 
concentration decreases from left to right. (a) Label-free image of the PC surface showing the 
presence of capture antibody spots on the sensor. (b) Fluorescence detection at a single 
resonance angle of 10° after assay is completed. (c) Fluorescence detection using the masked 
detection for the same PC surface showing improved contrast, recognition and uniformly higher 
fluorescence output.   
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Figure 3.7 Plot comparing the fluorescence intensities versus concentration of TNF-α for a 
measurement performed at a fixed angle of 10° and a scanned-angle measurement using the 
masked detection method.  
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CHAPTER 4:  QUARTZ-BASED PROTEIN MICROARRAY  
4.1 Introduction 
The use of specially designed instrumentation that complements PC biosensors can 
greatly enhance our ability to improve fluorescence output especially in the context of 
microarrays.  Sensitive and high-multiplexed imaging in concert with fluorescence enhancement 
can reduce the detection limits of protein microarrays and opens the door for an inexpensive 
means of early detection of cancer.  This exciting possibility has been demonstrated by 
performing simultaneous, multiplex analysis of 24 antigens on a single PC biosensor [32].  In 
this work, a single photonic crystal is used to visualize the panel of 24 biomarkers in an ELISA 
format using a fluorescence laser scanner (Tecan LS). The resonant excitation effect increased 
the signal-to-noise ratio by 3.8- to 6.6-fold, resulting in a decrease in detection limits of 5-90%, 
with the exact enhancement dependent upon the antibody-antigen interaction.  While this 
preliminary study has shown great promise for this technology, there are two significant 
limitations that we seek to overcome.  
The initial demonstrations of PCEF involved a PC biosensor that was fabricated using 
polymer materials via nano-replica molding process. This is an inexpensive method capable of 
producing PCs over large surface areas on flexible plastic substrates. However, the PC produced 
by this method has the significant drawback pertaining to the generation of autofluorescence 
from the polymer materials. This autofluorescence produces a background intensity that is 
indistinguishable from fluorescent photons generated by the assay, especially in instruments 
involving widefield imaging.  The autofluorescence background intensity thus limits the 
detection of analytes at the lowest concentrations. To counteract this issue we explored the 
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design and fabrication of PC biosensors that could be fabricated from materials (like quartz) 
exhibiting little or no autofluorescence.   
The fluorescence scanner, utilized with the plastic-based PCs, employs a focused beam 
that demands the use of broader linewidths for the PC resonance, as discussed in Chapter 2. This 
restriction on the Q-factor of the PC limited its ability to produce the enhanced fields that 
ultimately determine the level of fluorescence enhancement for surface bound fluorophores.  
Thus, the new sensor configuration was aimed at not only lowering substrate autofluorescence, 
but also improving the PC Q-factor in order to achieve the lowest limits of detection. 
The use of the quartz-based PC has been explored in the context of simple proof of 
concept assays in chapters 2 and 3. While the techniques have promised us lower detection limits 
for a quartz-based PC biosensors used in conjunction with a collimation illumination scheme, we 
needed to analyze the viability of this approach to a large scale protein microarray in order to test 
the value of this new technology. In this chapter, we explore the efficacy of the quartz-based PCs 
with a collimated illumination scheme by exploring a sandwich ELISA protein microarray with a 
panel 21 breast cancer biomarker assays.  
4.2 Materials and Methods 
4.2.1 Reagents 
(3-Glycidoxypropyl)trimethoxysilane (GPTS), phosphate buffered saline (PBS) powder, 
and Tween-20 were purchased from Sigma-Aldrich. Purified primary capture antibodies, 
antigens, and secondary detection antibodies were purchased from R&D Systems (Minneapolis, 
MN, USA), Lab Vision (Fremont, CA, USA), Fitzgerald (Concord, MA, USA), MBL 
International (Woburn, MA, USA), and BiosPacific (Emeryville, CA, USA) [52]. All detection 
antibodies were biotinylated by the supplier. Blocking solution containing 1% casein in PBS was 
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purchased from Bio-Rad Laboratories. Streptavidin-conjugated Cy5 (SA-Cy5) was purchased 
from Amersham Bioscience.  
Abbreviations of assays used in this chapter are: amphiregulin (AMR); basic fibroblast 
growth factor (bFGF); cluster of differentiation 14 (CD14); epidermal growth factor (EGF); 
epidermal growth factor receptor (EGFR); E-selectin (Esel); heparin-binding epidermal growth 
factor (HBEGF); c-erbB-2 extracellular domain (Her2); hepatocyte growth factor (HGF); 
intracellular adhesion molecule 1 (ICAM); insulin-like growth factor 1 (IGF-1); matrix 
metalloprotease 1 (MMP1); matrix metalloprotease 2 (MMP2); matrix metalloprotease 9 
(MMP9); platelet-derived growth factor AA (PDGF); prostate specific antigen (PSA); regulated 
on activation normal T cell expressed and secreted (RANTES); transforming growth factor alpha 
(TGFα); tumor necrosis factor alpha (TNFα); urokinase-type plasminogen activator receptor 
(uPAR); vascular endothelial growth factor (VEGF). 
4.2.2 Quartz PC fabrication and characterization 
The PC was fabricated by "step-and-flash" nanoimprint lithography (NIL) [22] using a 
Molecular Imprints Imprio 50 system. In brief, the quartz substrate was spin coated with a layer 
of Transpin (Molecular Imprints Inc.) for planarizing the surface before the imprint. An imprint 
resist (MonoMat, Molecular Imprint Inc.) was dispensed onto the substrate and a template with a 
8.75×8.75 mm2 of 1-D grating pattern was slowly pressed against the dispensed MonoMat 
followed by a UV exposure. The template was then released from the MonoMat. The imprint 
process was repeated to create a 2×8 pattern on a quartz substrate as shown in Figure 4.1(a). 
After the imprint, reactive ion etching was used to transfer the imprinted pattern into the quartz 
substrate. Finally, a high refractive index layer of TiO2 (thickness = 130 nm, n = 2.35) was 
deposited on top of the imprinted grating structure by RF sputtering. The resulting grating 
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pattern has a period of 400 nm with a depth of 40 nm and a duty cycle of ~50% as shown in 
Figure 4.1(b).  
The device was designed to have two resonances at TM-polarization (electric field 
perpendicular to the grating structure) to support the EF and LF detection modalities through use 
of two laser illumination wavelengths. The resonance condition of the quartz PC can be observed 
by measuring the dip in the transmission spectrum when the PC is subjected to broadband 
illumination as shown in Figure 4.1(c), where two transmission spectra are shown. When 
illuminated at normal incidence, the transmission dip is observed at λ~690 nm with a full width 
half maximum (FWHM) of Δλ = 3 nm. When light is incident at an angle of 11° there is a 
resonance at λ~633 nm with a FWHM of Δλ = 4 nm. The fiber-coupled broadband light source 
used in this experiment contains a moderate divergence; hence, the measured coupling efficiency 
is lower than that obtained via illumination by a collimated source, such as a laser [30]. Laser 
coupling efficiency at the resonant angle/wavelength combination has been measured to be 90% 
(data not shown).  
For the EF detection modality, the PC was designed specifically for the dye Cyanine-5 
(Cy5) due to its strong quantum yield and high absorption efficiency at the λ=633 nm 
wavelength of HeNe lasers. The PC was be tuned to an on-resonance condition by illuminating 
its surface using a TM–polarized wavelength of   λ=633 nm and corresponding incident angle of 
11°. This illumination condition resulted in an amplified near-field electric field intensity on the 
PC surface for enhanced excitation. The large illumination angle was designed to prevent 
excitation light from coupling into the objective lens and subsequently reaching the detection 
system. Despite the use of an excitation filter (OD 7) to block the photons at the laser wavelength 
from reaching the imaging CCD, this phenomenon, if not accounted for, would result in an 
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elevated “background” signal that can be greater than the desired fluorescence signal. The PC 
exhibited a second resonance at λ=690 nm, which spectrally overlaps with the emission spectra 
of Cy5. This resonance was used to more efficiently direct emitted photons towards the detector 
to obtain enhanced extraction [59]. The resonance at λ=690 nm at normal incidence angle was 
also used for the LF detection modality. Deposition of capture antibodies on the PC lead to a 
localized increase in the effective refractive index of the PC resulting in a shift in the resonance 
angle, where the shift in the AMT efficiency was proportional to the density of the deposited 
antibody.   
4.2.3 Microarray preparation and assay protocol   
The microarray preparation and sandwich assay format has been described in detail 
previously [50, 52]. In brief, to bind the antibodies to the PC surface, a self-assembled 
monolayer was applied by a vapor-phase technique to form a monolayer of 3-glycidoxypropyl-
trimethoxysilane (GPTS). Capture antibodies were diluted in PBS to a concentration of 0.8 
mg/ml, and 4 replicate spots per assay were printed in each array on a quartz PC slide using a 
noncontact NanoPlotter NP2 printer (GeSiM, Germany). The resulting spot size was around 150 
µm, which covered about 375 periods of the PC. Following the printing, the slide was incubated 
overnight at room temperature and 60% humidity. The slide was then blocked in 1% casein in 
phosphate buffered saline (PBS) solution. After washing in PBS with 0.05% Tween (PBS-T), the 
slide was incubated with a mixture of antigens and 0.1% casein in PBS with gentle agitation 
overnight. Dose-response curves were generated using three-fold dilution series of the antigen 
mixture for a total of seven concentrations, in addition to a blank (only dilution buffer, 0.1% 
casein in PBS). The slide was then washed in PBS-T, followed by incubation with a mixture of 
biotinylated detection antibodies at 25 ng/ml in PBS-T with mild agitation. The slide was next 
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washed with PBS-T and incubated in a solution of 1 µg/ml SA-Cy5 in PBS-T. Finally, the slides 
were washed and dried before fluorescence and LF measurements.  
4.2.4 Fluorescence and label-free measurements 
In order to measure both LF and EF intensities, the integrated EF/LF microscope system 
shown in Figure 4.2 was used. A detailed description of the instrument has been presented 
previously [28]. In brief, unlike an imaging system that uses a focused beam to excite 
fluorophores, the instrument used here provided a collimated laser illumination to provide 
efficient coupling to the PC.  Rather than scanning the PC surface, the system captured an image 
of an entire field of view at once. The system is equipped with a 35 mW HeNe laser, (λ=632.8 
nm) for the EF modality, and a 50 mW AlGaAs semiconductor diode laser (λ=690 nm) for the 
LF modality. Both excitation sources were TM polarized with respect to the PC grating lines. A 
beam expander produced an illuminated diameter of 4 mm with a divergence of 0.037°. A 
rotating diffuser was used to reduce speckle and fringes at the imaging plane by randomizing the 
spatial coherence of the laser. The incident angle was precisely controlled by a high precision 
angle-tuning gimbal-mounted mirror (resolution of 0.005°). The sample was imaged by an 
electron multiplying charge-coupled device (Hamamatsu, Japan) through a 4×-microscope 
objective (N.A = 0.1). A bandpass filter (Semrock, λ=690, Δλ=20 nm) that overlaps with the 
emission bandwidth of the Cy5 was used to prevent photons at the excitation laser wavelength 
from reaching the CCD during fluorescence imaging.  
For protein microarrays, the LOD was affected by the uniformity of the spot intensities 
from replicate spots present across an array. For a fixed incident wavelength of λ=633 nm, the 
PC resonant coupling condition has a full width half maximum in angle (FWHMθ) Δθ~0.4°. 
Recall from Chapter 2 that, while a narrow resonant coupling condition has been shown to 
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provide the greatest fluorescence excitation enhancement factor, the stringent conditions for 
optimal laser-PC coupling means that a small deviation of Δθ=0.4° from the true device resonant 
angle would result in a 50% reduction in fluorescence intensity. Therefore, a uniform 
enhancement effect over the entire array is critical. Variations in the optimal PC resonant 
coupling angle across an array can originate from the nonuniformity of the device during the 
fabrication process, nonuniformities in the surface chemistry layer, and nonuniformity in the 
density of antibody capture spots – both between spots and within an spot. In order to retain high 
signal amplification while achieving uniform signal enhancement across the whole microarray 
slide, we utilized the angle-scanning method detailed in Chapter 2. This accounts for variations 
in the resonant angle across the slide. Thus, rather than gathering a single fluorescence image 
using only one incident angle, a sequence of fluorescence images were captured over a range of 
angles that included the resonant angle. Image processing software compared the set of images 
taken at each angle, and selected the maximum intensity for each pixel. The maximum intensity 
for each pixel corresponds to the incident angle that matched the optimal resonant coupling 
condition. A composite fluorescence image was generated in which each pixel holds the 
maximum observed intensity value.  
To obtain LF measurements of the printed antibodies, the 𝜆=690 nm laser was used to 
illuminate the PC resonance over a range of incident angles near normal incidence. The AMT 
was determined by software on a pixel-by-pixel basis, where shifts in the AMT correspond to 
locations on the PC with greater immobilized antibody density. Before immobilizing capture 
antibodies, the PC resonance was designed to occur at λ=690 nm (when illuminated at normal 
incidence), resulting in a minimum transmission as shown in Figure 4.1(c). Using this technique, 
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a high-resolution spatial map of adsorbed captured antibody densities was generated as a 
function of position on the PC surface. 
4.2.5 Data analysis   
Spot intensities of the LF images were analyzed using GenePix Pro 6.1 software. The 
locations of the spots from the LF image were overlaid with the EF image to quantify the spot 
fluorescence intensities. ProMAT, a software package developed by Pacific Northwest National 
Laboratory specifically for the analysis of microarray data, was used to generate concentration-
response curves based on a four-parameter logistic model [60-62]. The LOD was also calculated 
by ProMAT, which is freely available at www.pnl.gov/statistics/ProMAT.     
4.3 Results and Discussion 
4.3.1 Label-free measurement of spot densities   
When antibodies are deposited onto a solid surface, they exhibit distinct substratum-
binding characteristics due to antibody-specific diversity that results in binding density 
variability. The LF imaging modality of the detection instrument can be used to characterize the 
antibody capture spot density on the PC surface. As shown in Figure 4.1(c), the PC exhibits a 
resonant reflection at λ=690 nm near normal incidence. The dielectric permittivity of surface 
biomolecules results in an increase in the resonant coupling angle that is proportional to the 
adsorbed mass area density, and the coupling angle increase is spatially localized to the regions 
of the PC surface where the biomolecule attachment occurs. Using computer control, the angle 
scanning mirror of the detection instrument (Figure 4.2) can be rapidly scanned through a range 
of angles in small increments (0°<θ<3° with Δθ=0.01°), and an image of the transmitted 
intensity can be gathered at each incident angle using the CCD imager. For each pixel, the AMT 
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was determined by mathematically finding the minimum of the plot of transmitted intensity as a 
function of θ, to generate a spatial map of AMT versus position on the PC surface with pixel 
resolution of 16 µm.  To account for any non-uniformity due to the PC fabrication or surface 
chemistry, two distinct AMT images were gathered.  An initial AMT image of the PC surface 
was obtained prior to deposition of antibody capture spots, and a second AMT was gathered after 
spot deposition.  The two images were aligned and mathematically subtracted  (after spots – 
before spots) to produce a spatial map of the AMT shift due only to the deposited capture 
antibodies. A representative AMT shift image of one set of immobilized capture antibody spots 
is shown in Figure 4.3(a) using the layout shown in Figure 4.3(b). The average net AMT shift of 
four replicates for each antibody is plotted in Figure 4.3(c), which depicts the variability of 
binding density obtained from the antibodies used in our array, despite the use of identical 
antibody concentrations, buffers, spotting conditions, and incubation conditions. After the 
deposition of antibodies, the AMT shifted roughly from 0.1° (for EGF and HGF) to 1° (for 
uPAR).  This wide range of resonant coupling conditions suggests that, during the subsequent 
enhanced fluorescent imaging (that was to be performed after exposing the array to analyte, 
secondary antibody, and Cy5/streptavidin labels), using a fixed incident angle to illuminate the 
entire array could not be expected to provide uniform fluorescence enhancement for every assay. 
The LF detection modality can be further used to identify the presence of missing capture spots, 
spots with nonuniform antibody density (either with heavy density in the spot center or around 
the spot periphery), or other spatial features that would render a capture spot useless for further 
analysis [47]. Through identification of spot deposition errors, specific spots can be flagged for 
exclusion from consideration in assay replicate statistics, thus providing a valid means for 
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reducing assay CV and LOD with information that is normally absent when using an ordinary 
glass surface. 
4.3.2 Angle scanning to achieve uniform enhancement   
As discussed previously, the PC enhanced excitation effect is highly sensitive to the 
resonant angle for collimated illumination. For the PC used here, FWHMθ < 0.4°. Therefore, a 
small deviation in illumination angle from the actual resonant angle would result in a significant 
drop in the signal enhancement. As indicated in the LF measurement, upon deposition of 
antibodies, the resonance angle can shift from 0.1°<Δθ<1°, depending on the density of the 
capture antibodies; thus, it is necessary to adjust the incident angle of fluorescent illumination to 
achieve the maximum enhancement for each spot. Rather than using a single fixed angle to scan 
the entire array, a series of 300 fluorescent images were captured for incident angle range of 
10.5°<θ<12.5° at increment of Δθ =0.01°. The 4×-objective used in EF/LF microscopy system 
yields a 2×2 mm2  field of view, which covers one of the replicates shown in Figure 4.4(a). For 
the angle-scanning method, it takes 9 seconds to capture 300 images to generate a final 
composite image for one replicate. There are four replicates per concentration and eight 
concentrations for a slide, so it takes less than 5 min to capture all the images for a single slide. It 
takes less than 6 min to scan a whole slide including the time for stage movement.   
The maximum intensity values for each pixel are used to generate a composite 
fluorescent image in which each pixel is represented at its optimal on-resonance coupling 
condition. For comparison, a single fixed angle intentionally selected at an off-resonance 
condition (θ=12.2°) for an array is shown in Figure 4.4(a), while the angle-scanning approach 
was used to generate the fluorescence image shown in Figure 4.4(b). GenePix Pro 6.1 software 
were used to quantify the median spot intensity. The CV were calculated as the standard 
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deviation divided by the average of these median spot intensities of four replicate spots for each 
assay from the third highest concentration well. The CV for each detection approach is compared 
in Figure 4.4(c), in which the angle-scanning method improves the CV by up to 99%. We 
observe that assays with the greatest antibody capture spot density, as measured by the AMT 
shift image, do not correlate to higher fluorescence intensities for detection of biomarkers.  We 
also observe that variability in the capture spot density does not correlate strongly with the CV of 
fluorescence signals (correlation coefficient ~0.5). These observations suggest that the antibodies 
exhibit distinct characteristics (such as stability and activity) so that higher antibody density does 
not necessarily result in greater sensitivity for detection of the corresponding biomarker.   
4.3.3 Standard curves and limit of detection   
The fluorescence intensity as a function of biomarker concentration was used to generate 
standard curves for each assay. Standard curves for two exemplary assays (PDGF and AMR) are 
shown in Figures 4.5(a)-(b), in which the angle-scanning and fixed angle (θ=12.2°) methods are 
compared. These results highlight the effectiveness of the PC surface for enhancing the 
fluorescence output when illuminated in the on-resonance condition, when compared to off-
resonance illumination for the fixed angle case. The plots also show that the angle-scanning 
approach provided a uniform enhancement effect, as evident by the low spot-to-spot CV for four 
replicate spots for each concentration. The coefficient of determination (R2) values of a 4-
parameter logistic curve fitting algorithm for PDGF was R2 = 0.98 and R2 = 0.96 for AMR using 
the angle-scanning method. However, using the fixed angle method, the R2 values for these 
assays significantly dropped to R2 = 0.75 for PDGF and R2 = 0.5 for AMR. Similar results were 
obtained for all the assays on the chip as shown in Figure 4.5(c). 
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Detection of weak signals above background fluorescence (generated from the 
combination of autofluorescence from the substrate and nonspecific binding) is especially 
important for detection of low concentration biomolecules [22, 36, 63, 64]. For an enhanced 
fluorescence substrate such as a PC, any autofluorescence from the substrate can be enhanced in 
parallel with fluorophores tagged to analyte molecules. Due to the low autofluorescence of the 
quartz substrate and high spot fluorescence enhancement, all the spot signals were higher than 
the background signals. This indicated that by using a quartz substrate, the sensitivity of the 
microarray was limited by the nonspecific binding by the various protein reagents and not the 
substrate itself.   
The limit of detection (LOD) is highly dependent on the affinity of the capture and 
detection antibodies for the biomarker; therefore a range of LODs is typically obtained for a 
multi-analyte array [55]. As our array is being developed for early breast cancer screening, a 
wide range of potential biomarker proteins, from a variety of protein families, were included. 
These include assays for cytokines, proteases, growth factors, receptors, and adhesion proteins – 
each with different affinities between the capture antibodies and their corresponding antigens.  
The LOD was calculated as the concentration corresponding to the mean of blank control 
spot intensities plus three standard deviations of the log-transformed fluorescence intensities 
from all concentration levels. Using the angle-scanning method for fluorescence detection, the 
LODs shown in Figure 4.5(d) were obtained, with values ranging between 6.3 and 500 pg/ml. 
Only assays with R2 > 0.95 from the four-parameter logistic curve fitting were included here. 
Due to inter-spot variability, the fixed angle scanning method resulted in poor curve fitting, (R2 < 
0.95). 
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Several assays are not included in Figure 4.5(c)-(d). These either exhibit poor 4-
parameter curve fitting (R2 < 0.95) or do not display sigmoidal dose-response curve behavior. 
For example, EGF generates fluorescence output that is not concentration dependent, indicating 
loss of function of either its capture antibody or detection antibody.  
4.4 Conclusion 
In this Chapter, we demonstrated a novel optically active PC surface and detection 
method that can substantially augment protein biomarker microarray analysis in two distinct 
ways. The quartz-based PC structure was chosen specifically for its low autofluorescence 
properties relative to previously demonstrated PCEF surfaces that were fabricated from polymer. 
The device structure was designed to produce two distinct and narrow resonant modes that 
enable two complementary imaging modalities to be performed in the same detection instrument. 
The label-free detection modality was used to quantify and visualize binding density variability 
of immobilized capture antibodies as a means for providing quality control and spot-quality 
screening. We were however not able to successfully translate all the work from Chapter 3 in 
using the label-free  modality for selective enhancement of fluorescence. We used an angle-
scanning fluorescence imaging approach for PCEF that automatically corrects for variability in 
optimal resonant coupling conditions that originates from the observed variability in antibody 
capture spot density.  The angle-scanning approach was successfully applied to multiplexed 
protein microarrays. The ability of the angle-scanning method to provide highly uniform 
fluorescent enhancement throughout an array was demonstrated through a substantial reduction 
in fluorescent intensity CV, as compared to measuring the same array with off-resonance 
illumination at a single angle. The combination of a quartz-based PC with a custom detection 
instrument that can optimally couple laser illumination into multiple PC resonances can be used 
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as a platform for a wide variety of surface-based fluorescence assays that would benefit from 
reduction of detection limits and the ability to measure the density of capture molecules. The 
limits of detection sensitivity presented here, however, still need to be reduced further in order to 
be competitive with current confocal technology.   
 
 
	  	  
65	  
4.5 Figures 
 
Figure 4.1 (a) Photograph of a 25 x 75 mm2 PC slide with an 8x2 pattern of 8.75 x 8.75 mm2 
imprinted grating regions, (b) SEM image showing cross section of a PC  and (c) transmission 
spectrum of both normal and 11° incidence. The resonance at λ=690 nm is used for label-free 
measurement and enhanced extraction of Cy5 emission. The excitation wavelength of λ=633 nm 
is used for enhance excitation of Cy5.  
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Figure 4.2 Schematic diagram of the instrument used for EF and LF measurement. The λ=632.8 
laser is used for fluorescence excitation, while the λ=690 nm laser is used for label-free imaging. 
The system incorporates a computer-controlled tunable mirror that is capable of scanning the 
incident angle through a range of angles. A 4x objective images a 2x2 mm2 field of view of the 
PC.  The CCD measures transmitted laser intensity as a function of incident angle at λ =690 nm 
for LF detection, and measures fluorescence emission intensity from the PC for EF detection. 
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Figure 4.3 Label-free characterization of the density of antibody capture spots by measuring 
shifts in the λ=690 nm resonance. (a) Image of the shift in the AMT for a representative array of 
antibody capture spots, representing a label-free measurement of the capture spot density. (b) 
Layout of the capture antibodies within an array. (c) Average net AMT shift values for the 
capture antibodies with error bars representing one standard deviation of from four replicate 
arrays on the same chip. Measurements indicate a large variability in capture spot density that is 
dependent on the specific antibody, but excellent reproducibility for a particular antibody.  
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Figure 4.4 (a) Fluorescence images from both (a) fixed angle method and (b) angle-scanning 
method from the third highest concentration. (c) Bar chart of CV comparison between two 
scanning methods shows that angle-scanning method greatly improves the uniformity of spot 
intensities.  
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Figure 4.5 Dose-response curves for (a) PDGF and (b) AMR where black and gray curves are 
from angle-scanning and fixed angle scanning method respectively. Error bars represent one 
standard deviation from four replicate spots. (c) Comparison of R2 for the 4-parameters logistic 
curve-fitting algorithm for both angle scanning and fixed angle methods. (d) LODs based on the 
angle scanning method. Only assays with R2 > 0.95 from four-parameter logistic curve fitting 
were listed here.  
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CHAPTER 5:  LINE SCANNING INSTRUMENTATION FOR PCEF 
5.1. Introduction 
The ability to effectively couple incident light to a PC supporting guided mode 
resonances for EF opens the door for new and powerful techniques.  A collimated illumination 
scheme in concert with a PC exhibits impressive fluorescence enhancement that can be used for 
improving DNA and protein microarrays by reducing the limit of detection. The label-free 
mechanism of a PC is an added advantage that can improve quality control of immobilized 
capture spots and allow for selective enhancement of spot fluorescence. The work presented in 
this dissertation and performed in our research group has brought the achievement of PC-based 
protein microarrays for early detection of cancer well within reach. However, while these 
preliminary studies show the great promise of this technology, there are significant limitations 
that we seek to overcome.   
We have already addressed several key improvements necessary to develop PCs as a 
platform for protein biomarker detection. In the wake of these developments, PCs can be 
optimally designed to take advantage of the resonant evanescent field that has an intensified local 
energy density compared to the excitation light source. A resonant mode of the PC is associated 
with a distinct resonant wavelength (λr) and resonant coupling angle (θr, ϕr). In Chapter 2, an 
illumination approach using an expanded and collimated laser beam was used to efficiently 
couple the light at λr into the target resonant mode, resulting in a fluorescence intensity 
enhancement factor of 600× compared to performing an identical assay on an unpatterned glass 
surface.   
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While an expanded laser illumination source enables imaging of a large field of view, it 
provides relatively low power density compared to a focused laser beam, thus compromising 
detection sensitivity. Figure 5.1 shows a bar graph plot of the SNR comparison for the PPL-
alexa-647 study done previously (Chapter 2). The plot shows that, while in the on-resonance case 
for a low autofluorescence substrate like quartz, the SNR is superior for collimated light. 
Furthermore in comparison to the >10× boost in signal enhancement shown in Figure 2.8, there 
is only a modest boost of <2× in SNR for the on-resonance case.  Another important piece of 
information conveyed by Figure 5.1 is that the SNR for collimated light in the case of an 
unpatterned glass substrate is far inferior to focused light (almost 10× lower).    
This is observation conveys some key insights. The PC stimulated with collimated light 
masks the effects of a low power density owing to its ability to generate enhanced fields adjacent 
to the surface. Thus SNR is not enhanced proportionally to the signal owing to inherently low 
power density. This fact is self-evident when comparing the SNR obtained on an unpatterned 
glass surface for a collimated beam versus a focused beam.  This is significant since the ultimate 
measure for the limit of detection is the SNR. Additionally, since this study was performed using 
an assay not requiring surface chemistry, the additional sources of noise present for a protein 
microarray are not factored here. It is thus critical to address the key limitations on SNR in order 
to develop a means to perform highly multiplexed cancer biomarker detection with biologically 
relevant detection limits. 
In this chapter, we discuss the development of a line-scanning apparatus as a more 
effective approach to tackling the issues of SNR without sacrificing on PCEF performance. We 
start by discussing the unique properties of a one-dimensional PC that make this design a 
possibility. Next we discuss the building of a transmission-based line-scanning instrument and 
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demonstrate its ability to enhance excitation for simultaneous detection of 21 cancer biomarkers 
at a high concentration. We move on to the motivation for a new design for the detection 
instrument. Finally, we present the most recent work in the design, characterization, software-
development and application demonstrations of an advanced design objective-coupled line-
scanning instrument built for use with the silicon-based PC.  
5.2 Design and Properties of a One-Dimensional PC 
A schematic diagram of the PC structure used in this work is shown in Figure 5.2(a). The 
one-dimensional grating structure was fabricated using nano-imprint lithography, which has been 
fully described in [22]. The fabricated PC structure has a period of Λ = 400 nm, duty cycle 50%, 
and a grating depth of d = 50 nm. The grating surface was coated with a 130 nm thick TiO2 
dielectric thin film (refractive index, n = 2.35). Under broadband illumination, a highly efficient 
reflection represents a resonance at a specific wavelength and a specific angle.  The photonic 
band diagrams of the PC were obtained by illuminating the device with collimated broadband 
light from a tungsten lamp, and analyzing the reflected light with a spectrometer (USB 2000, 
Ocean Optics) as a function of incident angle.  The measured band diagrams are shown in Figure 
5.2(b) and (c) when the angle of incidence is scanned from 0º to 12 º in ϕ and θ directions, 
respectively. As shown in Figure 5.2(b), the resonant wavelength changes dramatically when the 
angle of incidence (θ = 0º and 0º<ϕ<12º) varies perpendicular to the orientation of the grating.  
Using a narrow bandwidth light source, such as a solid-state laser (linewidth ~1 nm at λ = 639 
nm), a misalignment of incidence angle of 0.1º with respect to the resonant angle ϕr will reduce 
the coupling efficiency to the PC by a factor of 10.  However, the photonic band diagram shown 
in Figure 5.2(c) exhibits very small angular dependence (0.3 nm/deg) along the θ direction.  
Therefore, to efficiently couple light into the 1-D PC surface, the excitation laser beam only 
	  	  
73	  
needs to be collimated and tuned along the ϕ direction, while focusing the excitation light along 
the direction of θ can increase the power density supplied to fluorescent dye molecules and 
consequently improve fluorescence signal strength. For now however, we will focus 
demonstrating the ability of a line-scanning modality to work effectively with a 1-D PC. The 
line-scanning fluorescence imaging system described in the next section is designed to take 
advantage of this unique property of the 1-D PC. 
5.3 Transmission-Based PCEF Line-Scanner 
A schematic of the detection instrument is shown in Figure 5.3(a). A single-mode fiber-
coupled semiconductor laser diode (AlGaAs, 35 mW, λ=637 nm) was chosen as the excitation 
light source.  The output from the fiber is collimated using an aspherical lens (L1, fL1 = 30 mm) 
and subsequently focused by a cylindrical lens (C1, fC1 = 6.35 mm) into a line of 8 µm in width 
and 2 mm in length at the focal point of L1.  The beam profile of the line is shown in Figure 
5.3(b) and the profile along the line (z-direction) and across the line (x-direction) is plotted in 
Figure 5.3(c), showing the expected Gaussian line shape in the direction of focus. The intensity 
variation across the line is <20% for the ~2 mm length of the line. The width of the line in the x-
direction is ~8 µm. The output end of the fiber is positioned at the focal plane of L1.  Translation 
of the fiber in the direction perpendicular to the orientation of the grating enables adjustment of 
the incident angle (ϕ) from 0° to 20° with an accuracy of 0.02°.  The displacement (Δd) of the 
fiber from the focal point of L1 is related to ϕ by  𝜙 =    tan!! ∆!!!!       (5.1) 
In the plane of the PC surface, the line-shaped laser beam is orientated perpendicular to 
the direction of the PC grating.  The power density of the beam is calculated to be 2.1875 × 106 
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W/cm2, resulting in a ~250× greater power density than the collimated-illumination detection 
instrument central to work in Chapters 2-4. The fluorescence emission is collected by a 2× 
objective lens (Olympus PLAN N, N.A. = 0.06) and quantified by an air-cooled linear CCD 
camera. The PC is placed on a motorized sample stage (MS2000, Applied Scientific Instruments) 
that is translated perpendicular to the laser line for a fast scan (750 lines/second). The 
fluorescence image is constructed by sequential scanning across the sensor in 8 µm increments.  
A pixel resolution of 8 µm × 8 µm was used for all the fluorescence images reported in this 
work.   
To illustrate that illuminating with a line-focused beam has no discernible effect on the 
PC coupling efficiency, we measured the laser transmission efficiency through the PC as a 
function of ϕ, for both collimated and line-focused light as shown in Figure 5.3(d).  
5.3.1 Application to a protein microarray 
To demonstrate the line-scanning technique in a protein microarray application, we 
performed a microspot immunofluorescence assay.  The PC was prepared by immobilizing 
capture antibodies (shown in Figure 5.2(a)) for 21 breast cancer biomarkers. The specific details 
of the microarray preparation and sandwich assay procedure (including the concentrations of 
specific antigens used) can be found in [32]. In brief, to covalently bind the antibodies to the PC 
surface, a self-assembled monolayer of 3-glycidoxypropyl-trimethoxysilane was applied using a 
vapor-phase deposition system. Capture antibodies were diluted in PBS to a concentration of 0.8 
mg/ml, and 4 replicate spots per assay were printed in each array on a 1×3 in2 quartz PC slide 
using a noncontact NanoPlotter printer (GeSiM, Germany). Following the printing, the slide was 
incubated overnight at room temperature and 60% humidity. The slide was then blocked in 1% 
casein in phosphate buffered saline (PBS) solution. After washing in PBS with 0.05% Tween 
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(PBS-T), the slide was incubated with a mixture of biomarkers (Table 5.1) and 0.1% casein in 
PBS with gentle agitation overnight. The slide was then washed in PBS-T, followed by 
incubation with a mixture of biotinylated detection antibodies at 25 ng/ml in PBS-T with mild 
agitation. The slide was next washed with PBS-T and incubated in a solution of 1 µg/ml SA-Cy5 
in PBS-T. Finally, the slides were washed and dried before fluorescence measurements. 
The fluorescence enhancement capability of the transmission line-scanning setup was 
then demonstrated by performing fluorescence measurements on the representative microarray. 
Measurements were taken with the illumination angle configured for on-resonance or off-
resonance excitation. The biomarker analytes and the respective concentrations are all listed in 
Table 5.1.  The fluorescent images (shown in Figure 5.4(a) and (b)) consist of 2082 pixels × 
2016 lines with 16 bit gray-scale resolution.  First, the illumination angle was tuned to ϕ = 20º 
and the microarray was scanned. To perform the on-resonance measurement, the excitation angle 
(ϕ) was tuned to a value of ϕ = 7°. Figure 5.4(c) also shows the fluorescence signal for both the 
on- and off-resonance cases on an assay-by-assay basis. Threshold values for detection above 
background noise for both the on- and off-resonance cases are indicated by the two horizontal 
lines on Figure 5.4. In order to calculate the threshold values, it is necessary to characterize noise 
in terms of the average background signal and the standard deviation of the background signal. 
The background signal was defined as the fluorescent intensity outside of the printed antibody 
spots. Each threshold value was calculated as three standard deviations above the average of this 
background signal value. Selection of laser power, CCD gain, and integration time that allows 
measurement for both the on-resonance and off-resonance illumination is difficult.  In Figure 
5.4(c), it is observed that while many assays in the off-resonance case are below the detection 
threshold, many on-resonance assays provide fluorescence intensity that is greater than the 
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maximum intensity of the CCD. Considering only the assays that do not display a saturated 
response, the signal enhancement due to on-resonance illumination is approximately 90×. This 
enhancement factor is due only to the PC “enhanced excitation” effect, and does not include the 
additional effects of PC “enhanced extraction” of emitted photons, which has been shown to 
provide an additional ~10× enhancement factor [21, 30]. This significant improvement in signal 
output is a consequence of the highly efficient coupling that is achieved between a PC and the 
line-scanning instrument. 
5.4 Motivation for New Design 
The work in this dissertation thus far has been dedicated to the design and 
implementation of a multiplexed, sensitive and cost-effective platform for screening cancer 
biomarkers. The optical detection instrumentation discussed in the previous section is shown to 
be a simple platform fully compatible with a PC sensor that can be constructed using inexpensive 
and readily available parts. By utilizing immunofluorescence assays on a PC sensor, this 
instrument could offer a means for rapid and ultrasensitive detection of biomarkers to clinical 
and research laboratories. To this end, we demonstrated a laser line-scanning based apparatus as 
described in the previous section. The prototype transmission-based instrument is capable of 
coupling 88% of excitation laser power into the desired PC resonant mode, resulting in 90× of 
emission intensity enhancement.  
There were, however, some practical considerations that demanded a reconfigured 
design. First, the line-scanning instrument utilizes an imaging capability allowing for diffraction-
limited resolution in one dimension. However, focusing the sample for the instrument is not 
straightforward. The laser line needs to be focused onto the sample independently from the 
objective lens, which makes the system difficult to use. The user operation for a bench-top 
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instrument needs to be straightforward. Second, the system was still large owing to its 
transmission illumination scheme.  The transmission-based design also imposed practical limits 
on the spatial resolution (due to specialized holders and lenses) that would require us to scale up 
the costs significantly in order to lower the resolution. Finally, the sensor fabrication using nano-
imprint lithography made the production of uniform and consistent devices difficult. Since this 
was best way to produce low-background-fluorescence quartz PC devices in a cost effective way, 
we needed to move away from a transparent substrate. A silicon-based PC also offered low 
background fluorescence but is without the fabrication issues that accompany nano-imprint 
lithography. Silicon as a sensor substrate is, however, opaque to visible wavelengths and thus not 
suitable for use with a transmission-based system utilizing visible laser wavelengths for 
excitation. There was thus a clear need for a new system design to address all of these issues.  
5.5 Objective Coupled Line-Scanner 
In order to address these practical issues, we devised a new objective-coupled line-
scanner (OCLS) design. The new configuration eliminates the need to excite fluorophores from 
the backside of the sensor, allowing for the imaging of opaque samples, such as a silicon-based 
PC sensor and a metal enhanced fluorescence sensor.  By coupling both the excitation and the 
emission with same objective, the design reduces the complexity of alignment and focusing. The 
result is a robust and compact system capable of large area, high-resolution microarray imaging 
at a rapid rate.  
5.5.1 Design 
The schematic diagram of this new configuration is illustrated in the Figure 5.5. The 
illumination of this system consists of a 70 mw solid-state laser (AlGaAs) at 637 nm, coupled to 
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a polarization maintaining fiber, a half wave plate, a cylindrical lens, a long pass dichroic mirror, 
and a 10x objective (Olympus Plan N) of focal length 18 mm. The fiber tip is coupled to a fiber 
collimator giving a highly collimated output beam 3.4 mm in diameter. The output beam is then 
passed through a half-wave plate, which is used to rotate the polarization of the output beam to 
match with the PC-mode to be excited. The laser beam is then focused to a line by the cylindrical 
lens (f = 100 mm). The focused laser line is directed onto the back focal plane of the microscope 
objective via a dichroic mirror. The output of the objective is thus a laser beam focused to a line.  
The PC is placed on a motorized sample stage (MS2000, Applied Scientific Instruments) 
that is translated perpendicular to the laser line for a fast scan (750 lines/second). The 
fluorescence image is constructed by sequential scanning across the sensor in fixed increments. 
The image acquisition process is discussed later in this section. The PC, placed at the focal plane 
of the infinity corrected 10×-objective (f0 = 18mm), interacts with a beam that appears 
collimated in one plane but focused in the other. The theoretically expected line width of a 
focused beam is given by  𝑤! =    !!! !! ,      (5.2)  
where λ is the wavelength of the laser beam, f is focal length of the focusing lens and D is the 
diameter of the incident beam. The theoretical linewidth of the beam focused on the back focal 
plane of the objective is calculated to be 23.85 µm. This will be important when characterizing 
the angle of divergence for the incident beam. The theoretical linewidth in the front focal plane 
of the objective is calculated to be 4.29 µm. This is subject to the assumption of a perfectly 
Gaussian beam and perfectly aspherical lenses. In reality this linewidth is probably slightly 
larger. 
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The assembly of the cylindrical lens, half-wave plate and fiber collimator are mounted on 
a two-dimensional stage. The stage is manually adjustable in one plane and automated in the 
other. The manual adjustment is utilized to fine-tune the focus of the beam onto the back focal 
plane of the objective lens. In order to achieve angle tuning, the line-focused beam is translated 
on the back focal plane of the objective, by tuning the position of the cylindrical lens-wave plate-
fiber collimator assembly. This fine stepping is achieved by utilizing a motorized linear stepping 
stage (Zaber LSM-25). The result is a change in the incident angle in the ϕ direction as described 
in Equation (5.1); here the focal length used would be that of the objective lens. The emitted 
fluorescence signal is collected by the objective and projected onto a CCD camera (Hamamatsu 
9100C) by a tube lens (f=150 mm).  A bandpass fluorescence filter is inserted between the 
objective and tube lens to block the excitation laser beam.  
The ultimate goal of the newly designed OCLS is to have good compatibility with the PC 
while exhibiting improved spatial resolution, and sensitive detection in a multiplexed format. 
With these specific goals in mind it is important to effectively characterize each of these design 
parameters in the context of the new instrument. 
5.5.2 Beam characterization: beam profile 
In order to characterize the design parameters of the system, it was first important to 
understand the size and shape of the beam as well as the degree of collimation. In order to 
characterize the degree of collimation we utilize a parameter, beam divergence. For a beam 
focused in the back focal plane of a lens, the beam divergence of the resultant collimated beam is 
dependent on the diameter of the focal spot and focal length of the collimating lens. This 
divergence is given by  
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𝛼 =    tan!! !!! ,      (5.3) 
where D is the diameter of the focused spot and f is the focal length of the collimating lens. In 
the case of a line focused beam emerging from the objective, the beam divergence is equivalently 
given by replacing the D by the linewidth of the line focused on the back focal plane. This gives 
us a divergence in the collimated direction given as 0.037°. This is a similar beam divergence to 
the case of the collimated beam in the PCEF microscope discussed in Chapter 2. This promises 
coupling efficiencies to PCs that should be comparable to the previous generation of the 2D 
collimated instrument, so long as the device configuration is comparable.  
 After gaining a good estimate of the collimation for our line-focused beam in one 
dimension, it is important for us to now characterize the beam profile in both dimensions. We 
utilized a piece of silicon wafer cut in the shape of a 1×3 inch standard glass slide to aid us in 
this study. We spin-coated SU8 polymer doped with LD 700 dye on the sample. Next we utilized 
a USAF photo mask to pattern the substrate with a standard line pair image through a simple 
contact lithography process. The final cured sample was then placed in a developer to remove the 
uncured photoresist. The sample was then scanned using the OCLS, and the final assembled 
image is shown in Figure 5.6(a). Each pixel in Figure 5.6(a) is indicative of 2×2 µm area. The 
scan direction (x-direction) and line orientation (z-direction) are indicated on the figure. The dark 
parts contain no dye or photoresist, while the bright part contains both. A single image captured 
of the laser line fluorescence is shown in Figure 5.7(a).    
To analyze the beam profile in the x-direction and z-direction, we first observe the plots 
of the line profiles given in Figure 5.7(b). Notice that the line profile indicates a Gaussian beam 
in both directions; however, the linewidth in the x-direction is much narrower owing to the 
focusing of the line. The full width at half maximum indicates a linewidth of ~6 µm which is 
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consistent with the theoretical value of 4.29 µm calculated previously. The value is 
overestimated due to various reasons including pixel width limitation and imperfect lenses. For 
the final image in Figure 5.6(a), the distribution (Figure 5.6(b)) in the x-direction is no longer 
observed, but, the Gaussian distribution z-direction persists. This is due to the fact that, the final 
image is a series of “line images” that have been assembled using a stitching algorithm. The 
specifics of the algorithm are discussed later in this chapter; the important point to note here is 
that the final image and the beam profile provide us with two specific insights to consider while 
performing our measurements. 
First, the line-profile in the z-direction will dictate the limit on the “spot-size” that can be 
accurately measured. An analysis of the signal intensity shows that there is a <15% variability in 
signal in the x-direction for the entire image. A similar variability in signal in the z-direction 
requires us to sample only 65 µm on either side of the midpoint. Recall from Chapter 2 that the 
acceptable spot CV for a microarray experiment is <20%. Thus if we performed a microarray 
experiment with this beam profile, our spot CV would be influenced by <5% as long we ensured 
that our assay spot diameter was no larger than 130 µm or, in the case of multiple spots, that the 
spots were present within a 130 µm band in the middle of the image. This is an important 
consideration when designing our assays. The second important insight we gain from this 
analysis is that, for a single measurement in a fluorescence assay like microarray, it is critical 
that all spots associated with a particular assay must be oriented in a linear fashion along the x-
direction. For quantifiable data, it is critical that the spot intensity not be influenced by 
superposed beam intensity distribution. Keeping all assays in a linear fashion along the scan 
direction (x-direction) ensures that the data from spot to spot are comparable and that the spot 
CV for a given assay is kept at a minimum. There are other more creative ways of orienting the 
	  	  
82	  
spots that can allow us to utilize multiple rows of spots; however, for the sake of simplicity we 
restricted our format to one row per assay. 
5.5.3 Sensor design: silicon-based PC  
Before we discuss any applications of the OCLS, we must first briefly discuss the design 
and fabrication of the silicon-based PC. The new PC design is a nanostructured surface grating 
patterned in a thermally grown, low-refractive-index silicon oxide (SiO2) layer atop a silicon 
handle wafer. The grating pattern with a fixed period and duty cycle is created and etched into 
the silicon oxide layer. The final step is the coating of the grating with a high refractive index 
titanium oxide (TiO2) layer. The periodic arrangement of the high (TiO2) and low (SiO2) index 
layers results in a characteristic narrow-band resonance peak and local electric field 
enhancement. A cross-sectional view of the device schematic is presented in Figure 5.8(a). As 
mentioned previously, the major advantage of this sensor design over the previously discussed 
quartz-based PC is in its fabrication. The devices can be fabricated on a wafer scale with 
semiconductor process technology and are thus amenable to inexpensive, high-volume 
manufacturing. This is achieved without increasing the levels of autofluorescence previously 
reported for the quartz-based PC. 
The first prototype devices were fabricated using a nano-imprint lithography process that 
has been reported previously [22]. Briefly, a thermal oxide with a thickness of ~ 800 nm was 
grown on a silicon wafer (4 in diameter, double side polished). The wafer was then planarized by 
coating with a polymer (Transpin, Molecular Imprints, Inc.) and hard-baked in preparation for 
the imprint lithography. The step and flash imprint lithography (SFIL) process was carried out 
using the Imprio-55 (Molecular Imprints, Inc.) and an imprint template where the grating pattern 
was created in a 9 x 9 mm2 area; the template was created using electron beam lithography and 
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reactive ion etching (RIE). First an imprint resist (Monomat, Molecular Imprints, Inc.) was 
dispensed onto the wafer in a precisely controlled pattern to optimize the fidelity of the pattern 
transfer from the template. Next, the template was brought into contact with the dispensed resist 
sitting on the wafer and the resist was cured by a short UV exposure. The template was then 
released and this SFIL process was repeated to cover the area of the wafer. After the imprint 
lithography was completed, three reactive ion-etching steps were performed to transfer the 
imprinted pattern from the resist layers into the silicon oxide layer. The wafer was then cleaned 
to remove any residues of polymers that were used as etch masks. After cleaving the wafer into 
smaller pieces, fabrication was completed by sputtering a layer of TiO2 (thickness of ~ 120nm) 
over the grating. Scanning electron micrographs showing the surface characteristics of these PCs 
are presented in Figure 5.8(b)-(d).  
While our nano-imprint lithography tool is well suited for prototyping, we were 
unsuccessful in using the tool to produce several full wafers in a university cleanroom setting. 
Instead, we turned to a commercial vendor (SVTC Inc.) for the large-scale fabrication of these 
devices. The previously mentioned simulation tool for rigorous coupled wave analysis 
(DIFFRACTMOD, RSoft) was used to aid in the optimal design of a PC device that provided 
maximum electric field enhancement for a TM mode at 632.8 nm. Simulation results dictated the 
use of a structure with a period of 360 nm, a duty cycle of 36%, a grating depth of 40 nm, and a 
TiO2 thickness of 120 nm. 
A proprietary process using DUV lithography and RIE was used to transfer the grating 
pattern from the template to the full area of an 8 in wafer. Scanning electron micrographs and 
atomic force micrographs showing the surface characteristics of these PCs are presented in 
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Figure 5.9. The wafer was diced to produce 1 x 0.5 in chips that were then coated with TiO2 to 
complete the device. 
5.5.4 PC coupling characterization: wavelength and angle spectrum  
 The success of a PCEF-based OCLS is critically dependent on its ability to effectively 
couple light into a PC. As described previously in Chapter 2, the degree of coupling plays a 
critical role in the enhancement factor achievable by a PC-Instrument combination. We had 
previously discussed our characterization method for a transmission-based system. The process 
involved the measurement of the wavelength spectra associated with the PC. This was done to 
ensure suitable positioning of the resonance transmission dip for the PC. The angle spectrum of 
the PC was then measured at a fixed laser wavelength. The percentage of transmitted light at the 
resonance condition was indicative of the coupling efficiency of the PC with the instrument. 
This system is however not suitable for our opaque silicon-based PC introduced in the 
previous section. For this purpose, we developed an angle-tuned reflection system that allowed 
for the measurement of the wavelength spectrum. The schematic of this setup is given in Figure 
5.10.  The setup consists of a tungsten halogen lamp (white light), which is coupled to an optical 
fiber (Ocean Optics Inc.) with a 50 µm core. The output of the fiber is collimated using an 
achromatic lens. The white light is polarized using a linear polarizer (Thorlabs Inc.) and 
projected onto the photonic crystal device that is held in a customized holder. The setup design 
takes advantage of the 1-D PC’s relative insensitivity to angle change in the θ-direction as 
described in section 5.2. The PC holder is oriented at a fixed angle of θ = 5°. The detector is 
placed at distance of 150 mm from the base of the PC holder and tilted up by 2θ = 10°. This 
orientation allows for detection of the reflected spectra at normal incidence. The detector height 
is lower than the height of the illumination beam and is composed of another collimator, which is 
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coupled to a 50 µm core fiber. The other end of the fiber is coupled to a visible spectrometer 
(Ocean Optics Inc.). Utilizing commercial software (Spectra suite, Ocean Optics Inc.), we are 
able to measure the reflected spectrum.  
In order to measure the reflected wavelength spectra off normal, we mount the PC holder 
on a rotation stage. This stage is then mounted on a 180 mm custom arm that contains the 
detector mount at the other end. The arm is then sandwiched by another rotation stage. This is 
depicted in Figure 5.10. In order to measure the reflected wavelength spectrum at an angle of 
incidence ϕ, we rotate the top rotation stage by ϕ clockwise and the bottom stage by 2ϕ 
counterclockwise. This allows the detector to collect the reflected wavelength spectra at all the 
angles. Each spectrum is normalized using a gold reflection mirror. It is important to compare 
reflection and transmission efficiency to estimate the loss in light due to scattering. The reflected 
and transmitted wavelength spectra for a transparent PC sample at normal incidence and at 2° are 
shown in Figure 5.11(a) and (b) respectively. There is a small drop in efficiency when comparing 
transmitted and reflected wavelength spectra both on and off normal. This is an important 
consideration when interpreting data from a silicon PC that is opaque. Figure 5.12(a) shows the 
reflected spectra for a silicon PC both at normal and at 3.5 degrees (resonance peak at the laser 
wavelength of 637 nm). The peak linewidth at the laser wavelength is 2 nm. 
Next we move on to measuring the angle spectrum of the PC at the fixed laser 
wavelength of the OCLS. We utilized simple Fourier optics that suggests that a change in 
position in the back focal plane results in a change in angle in the front focal plane. As 
mentioned previously, the assembly of the cylindrical lens, half-wave plate and fiber collimator 
are mounted on a two-dimensional stage. Once the line-focused beam is positioned on the back 
focal plane of the objective, any incremental translation away from the principal axis of the 
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objective will result in a corresponding angle change in the front focal plane given by Equation 
(5.1), where Δd is the displacement from the principal axis; here fL1 = fo is the focal length of the 
objective lens. Therefore, in order to tune the angle by 0.01°, we need to translate the beam by 
Δd = 0.003 mm or 3 µm (taking fo = 18 mm for the objective). This requires the use of a very 
precise linear stepping stage. We therefore make use of a Zaber, programmable stage with 
default resolution of 0.05 µm and a repeatability of <1 µm. This motor was a low cost solution to 
fast, automated angle tuning without compromising too much on accuracy and control. A sample 
spectrum captured for the silicon device is given in Figure 5.12(b). The reflection efficiency 
shows a coupling efficiency that is in the range spectra measured using the 2-D collimated light 
based system, discussed in Chapters 2 and 3. The linewidth of the angle spectrum is 0.4°. The PC 
is therefore effectively coupled with a narrow linewidth resonance peak. Next we discuss the 
image acquisition scheme before we move on to the discussion on the PC enhancement factor 
and the limits of detection in the context of a protein biomarker detection experiment.  
5.5.5 Image acquisition software and processing algorithm  
The image acquisition for the OCLS was fully automated using a C# based user interface. 
The software provides a synchronous integration of the various components of the OCLS. The 
drivers for the Hamamatsu EMCCD, Zaber linear stepping motor and the ASI XYZ-sample stage 
were written individually and then synchronized using a single program. The final software has 
the ability to capture the angle spectrum of a PC as well as perform fluorescence measurements. 
We utilized the information about the beam shape and size in order to set up an acquisition 
scheme. The user interface requires inputs of start and stop positions for defining a XY scan 
range and an angle scan range. The step size for the XY scan range is defaulted as 2 µm. This is 
the effective width of an individual pixel on the CCD. As discussed previously, the width of the 
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beam is measured to be 6 µm. Thus we oversample our images by a factor of 3 in the scan 
direction. The oversampling is done so that only the peak intensity at each pixel is used to 
generate the image. If we were to utilize a step size equal to the focus beam width, we would 
encounter a variability of ±25% in the scan direction as opposed to a variability ±6%. The 
tradeoff here is a 3× slower scan speed due to the shorter step size.  
The motivation for the new image-processing algorithm came as we recognized that by 
only selecting the peak intensity value, we effectively discard valuable data from the lower 
intensity pixels adjacent to the peak. The image-processing algorithm works on the assumption 
that, as we step through a 6 µm region, we are illuminating the region with a different intensity 
beam. If we aggregate the fluorescence emitted for all three frames, our final intensity value for 
that pixel should be >2× without increasing the laser power or integration time. Thus if we do 
need to oversample in steps to achieve the lower variability in the scan direction, we can utilize a 
clever algorithm to artificially enhance the integration time as well. This algorithm is depicted in 
Figure 5.13. Position 2 indicates the peak value that we would normally utilize and the processed 
peak indicates the aggregated intensity value we obtain. Owing to this processing algorithm we 
further noticed that we lowered the variability in the scan direction by 3×, due to the flat-top 
effect for a Gaussian profile. Theoretically, a Gaussian convolved with a Gaussian gives a flat-
top beam. This algorithm results in an optical convolution that allows reduction of variability and 
hence noise.  
5.6 Detection of Protein Biomarkers: Comparison with Current Technology 
In this chapter so far we have discussed the design and characterization of the OCLS as 
well as the silicon-based PC. In order to demonstrate our ultimate objective, a substantial 
improvement in detection sensitivity over current microarray technology, we utilize a protein 
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biomarker nanoarray.  In this sub-section, we first discuss the process of surface 
functionalization for our PCs. We then discuss the immunoassay protocol for the protein 
biomarkers. Finally, we interpret the results and compare the data obtained from a commercial 
confocal scanner on a glass slide and our silicon-based PC using the OCLS.  
5.6.1 Surface functionalization 
The PC devices were functionalized using a vapor-phase epoxysilane process. The 
epoxysilane chemistry was chosen for its low background fluorescence and high binding 
capacity to capture antibodies. The devices were first cleaned by sonication in 2 in petri dishes of 
acetone, isopropanol, and deionized (DI) water for 2 minutes each. The devices were then dried 
in a stream of N2 and then treated in an oxygen plasma system (Diener) for 10 minutes (power of 
100 W, pressure of 0.75 mTorr). The backside of each device was then adhered to the inside of a 
screw top lid of a 2 in glass container. At the base of the container, 100 µL of (3-
Glycidoxypropyl) trimethoxysilane (GPTS, Sigma Aldrich, Saint Louis, MO) was placed and the 
screw top lid was securely placed over the dish. After securely tightening the lids, each dish with 
a device adhered to its lid was placed in a vacuum oven for an overnight incubation at a 
temperature of 80 oC and a pressure of 30 Torr. The devices were then detached from the lids 
and sonicated in 2 in petri dishes of toluene, methanol, and DI water for 2 minutes each and dried 
under a stream of N2.  Standard glass microscope slides that served as controls were also 
silanized using the same protocol but with appropriately sized glassware. 
5.6.2 Fluorescent sandwich immunoassay 
The protein nanoarrays were produced using a desktop nanofabrication system, 
NLP2000, based on DPN technology (NanoInk Inc., Skokie, IL, USA).  Prior to printing, the 
tips, DPN Probes type M-ED Side M-2 with 12 A frame cantilevers (NanoInk Inc., Skokie, IL, 
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USA), with a pitch between each pen of 66 µm, were plasma cleaned for 40 second at low RF-
value, using a gas mixture of oxygen/argon (21% / 79%) at 200 mTorr using a Plasma Cleaner 
(PDC-32G) (Harrick Plasma, Ithaca, NY, USA). Two types of cytokines, interleukin 3 (IL-3) and 
tumor necrosis factor (TNF-α) (R&D Systems Inc., Minneapolis, MN) capture antibodies were 
printed on epoxysilane modified PC slides and Nexterion 1 x 3 in Slide E (Schott AG, Maintz, 
Germany) control glass microscope slides. The printing was performed under a controlled 
environment using an environmental chamber (ambient temperature and 30% relative humidity).  
The antibodies (~5.0 mg/mL) where diluted in proprietary printing buffer (NanoInk Inc., Skokie, 
IL, USA); the printing buffer is formulated to keep the protein moisturized and to preserve their 
active and folded states. Four pens out of 12 were used to print two cytokine, a positive control 
(goat-anti Rabbit IgG) at 2.0 mg/mL and a negative control (Normal Rabbit IgG labeled with 
Alexa-Fluor-555) at 3.2 mg/mL. Each PC hold 10 subarrays and the glass slides hold 48 
subarrays in a 4 × 12 format; each subarray contains 4 sets of 4 replicate spots per antibody for a 
total of 16 spots. The printed substrates were incubated in a sealed box with a desiccant for two 
days at 4 °C.  Next, the slides were placed in a 48 well format slide module assembly (NanoInk 
Inc., Skokie, IL, USA), were each well could hold up to 12 µL.  The arrays were blocked with 
casein blocking buffer (BioRad, Hercules, CA) for 1 h.  All incubations were performed at room 
temperature.  The arrays were then washed three times with 0.01% (v/v) Tween 20 in PBS 
(PBST) and then each well was incubated with a 10 µL mixture of different antigens 
concentration in casein buffer for three hours. This was followed by three rinses in PBST after 
which the glass slides were incubated in a bulk dish with 2 ml mixture of 1µg/mL biotinylated 
detection antibodies while the PC substrates were incubated with only 10 µL of the biotinylated 
detection antibody mixture in each well of the slide module assembly for 1 hour. The PC 
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substrates and glass slides were then washed three times with PBST, followed by the incubation 
with a 1 µg/mL solution of Alexa-Fluor-647 conjugated streptavidin (Invitrogen) for 30 minutes. 
Finally, the devices were washed 5 times with PBST and followed by a quick dip in DI water (3 
second) to remove the salt, spin-dried and then scanned. Antigen standard curves were generated 
by using a 3-fold dilution scheme for a total of 8 concentrations. The starting concentrations for 
IL-3 and TNF-α were 16.6 ng/mL and 2 ng/mL, respectively. 
5.6.3 Fluorescent data acquisition and analysis  
The fluorescence detection capabilities of the objective coupled line-scanning setup were 
compared to that of a commercial confocal microscope (Tecan LS) in the context of a protein 
biomarker detection experiment. Fluorescence data was acquired on the PC using the line-
scanning instrument while the control glass slide was scanned using a confocal microarray 
scanner equipped with a 632.8 nm laser line. The angle tuning capability of the OCLS was 
utilized to tune to the resonance angle. The incident output power from both the confocal scanner 
and the OCLS lasers were kept at a constant value of 5 mW. The data was then processed using 
the algorithm described in this chapter.  Finally, ImageJ was used to quantify the spot and slide 
background intensities and Prism (Graphpad) was used to fit the fluorescence data from the dose 
study.  
The representative images for the glass slide with the confocal scanner are shown in 
Figure 5.14(a) and (b). The images were captured at a resolution of 4 µm and at a PMT gain of 
180. The data for each concentration is shown in Table 5.2 for IL-3 and Table 5.3 for TNF-α.  
Figure 5.14(c) and (d) show the dose-response curves for the 5 measurable concentrations for IL-
3 and TNF-α respectively. The lowest detectable concentration for TNF-α was 0.025 ng/ml and 
IL-3 was 0.21 ng/ml.  
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Representative fluorescent images of the Si-PC captured with the OCLS are shown in 
Figure 5.15(a) and (b). The data for each concentration is shown in Table 5.4 for IL-3 and Table 
5.5 for TNF-α The images were captured as previously described. The CCD sensitivity gain was 
varied from 0 to 250, which translates to a signal boost by a factor of 4 to 1068 in an exponential 
trend [Hamamatsu Inc.]. The gain used to capture the seventh lowest concentration was 200, 
which is a multiplicative factor of 315. Thus when comparing this signal to the signal of the first 
assayed concentration, we must multiply the signal by a factor of 315/4.  This effect must be 
taken into consideration when comparing different concentrations captured at different EM-
gains. The dose-response curves in Figures 5.15(c) and (d) have 7 of the 8 assayed 
concentrations represented. A zoomed-in view of the curves provides a better view of the 4 
lowest concentrations (highlighted in the blue box). The red line here represents the background 
fluorescence value. The lowest detectable concentration here is 0.023 ng/ml for IL-3 and 0.0027 
ng/ml for TNF-α.  
5.7 PC-Enabled Enhanced Excitation of Localized Surface Plasmons in Isolated Gold 
Nanorods 
5.7.1 Introduction 
The study of light-matter interactions, or plasmonics, has led to the discovery of  myriad 
applications ranging from biological and chemical sensing to spectroscopic techniques [65-69]. 
Research in the field of plasmonics has been dominated by the study of materials supporting 
surface plasmon resonance (SPR), the phenomenon of coherent oscillations of the surface 
conduction electrons excited by electromagnetic (EM) radiation [69]. Since the experimental 
demonstrations and subsequent commercialization of SPR spectroscopy [70, 71],  SPR sensors 
have gained popularity in label-free sensing of biomolecular interactions. The propagating 
	  	  
92	  
plasmons (or surface plasmon polaritons) [72, 73] are used as a sensing platform to detect 
changes in the resonance condition owing to interaction between a metal-surface confined EM 
wave and a molecular surface layer of interest. While this technique has dominated commercial 
instrumentation, recent advances in fabrication have allowed for controlled fabrication of metal 
nanostructures on a subwavelength scale. This opened up an avenue of research in the use of 
localized surface plasmon resonance (LSPR) spectroscopy for sensing [74-77].  SPR and LSPR 
spectroscopy are capable of providing kinetic and thermodynamic data for binding processes. 
While SPR spectroscopy has a higher sensitivity to bulk refractive index change, the detection 
sensitivity is comparable for small changes in refractive index resulting from monolayer 
adsorption [78, 79]. This is owing to the smaller sensing volume for LSPR resulting from a 40-
50x EM-field decay length, making LSPR sensors more desirable for high-resolution 
experiments [80, 81]. Furthermore, since LSPR wavelengths are tunable by adjusting the 
dimensions and shape of a nanoparticle, the advanced synthesis techniques make LSPR-based 
sensing extremely flexible [82-84]. However, both SPR and LSPR spectroscopy have an inherent 
lack of analyte selectivity.  
The use of Raman spectroscopy has proved to be a promising alternative to address this 
desire for analyte selectivity. The Raman spectrum of a molecule provides us with a unique 
signature for a given chemical structure. This molecular fingerprint can be used to distinguish 
between similar changes in refractive index by attributing them to specific molecules. Raman 
spectroscopy, however, relies on the detection of inelastically scattered monochromatic light that 
is an extremely weak process. With the advent of surface-enhanced Raman scattering (SERS), 
there have been several proposed configurations for the amplification of radiative Raman cross-
sections owing to electromagnetic enhancement of the localized surface plasmons. While these 
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techniques promise very high enhancement of Raman signal, the bulk of the research is 
concentrated on the use of ordered structures to create LSPR coupling between adjacent particles 
(or structures). There has been very little work done on the detection of Raman signal by 
enhancing the LSPR oscillations alone in isolated nanoparticles [72, 73, 85-87]. Most of this 
work has been refocused to dimer fabrication [88] and dimer-based Raman detection [89-91] or 
single particle and metal layer coupled Raman enhancement [85, 92]. While isolated 
nanoparticles provide us with a unique opportunity to study very small sensing volumes and 
potentially single molecule sensing, they suffer from the same issues as Raman spectroscopy or 
weak signal.  In this section, we introduce a means of Raman enhancement for isolated gold (Au) 
nanorods by utilizing the properties of a photonic crystal (PC) biosensor to produce enhanced 
electric fields close to the surface when the resonance condition is met. These fields can be 
coupled with the LSPR modes of the nanorods for enhanced excitation.  
5.7.2 Device structure 
The schematic of the PC used in this study is shown in Figure 5.16(a).  The grating is 
fabricated on a silicon substrate by a commercial vendor (STVC Inc.). The grating is transferred 
on to an 8” silicon wafer using a proprietary process that utilizes deep UV lithography followed 
by reactive ion etching. After the patterning is finished, a high refractive index (n=2.35) layer of 
TiO2 is deposited as a light confinement layer that supports the establishment of optical 
resonances.  The electrical field associated with the resonant mode extends from the device 
surface into the surrounding medium. It is this electric field that we aim to couple into the LSPR 
mode of gold nanorods. The resonant mode of the PC has a particular wavelength and angle of 
incidence associated with it and is determined by the geometry of the structure [24, 93, 94].  For 
the purposes of this study, we designed the PC to exhibit strong optical resonances at λ=637 nm. 
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This wavelength overlaps with the excitation laser wavelength and the absorption spectra of the 
gold nanorods.  In order to efficiently couple the laser with the PC and thus obtain maximum 
electric field enhancement for the TM resonance mode, we selected the geometric parameters 
using rigorous coupled wave analysis (Diffract Mod, Rsoft Design). A grating period of Λ=360 
nm, grating depth of d=40 nm, 65% duty cycle, and t=120 nm thick TiO2 coating were 
determined to be the optimal characteristics.  The PC surface was fabricated over the entire 8 in 
silicon wafer and then diced into 1 × 0.5 in samples. An SEM image of a cross section of the PC 
surface is presented in Figure 5.16(b). The wavelength spectrum of the PC at normal incidence 
and at the resonance condition for illumination with a λ=637 nm laser is shown in Figure 5.16 
(c).  
5.7.3 Assay for Au nanorods on a PC 
In order to verify our hypothesis and theoretical findings, we prepared a silicon PC with 
sparsely dispersed Au nanorods. A 3D schematic of the final substrate is shown in Figure 
5.17(a). Figure 5.17(b) shows a 2D schematic representation of the stack of the layers deposited 
on the TiO2 surface following the assay. Figure 5.17(c) shows a top view SEM of the PC with 
Au nanorods distributed randomly on the surface. The inset in Figure 5.17(c) shows a blown up 
view of a single nanorod on the PC surface. The Au nanorods used in this study were synthesized 
using a previously described protocol [95]. The size (15x30 nm) and aspect ratio (=2) was 
selected to align the dominant absorption spectrum peak (638 nm) (Figure 5.17(d)) with the 
excitation laser wavelength (637 nm). The synthesized gold nanorods are borne by a positively 
charged cetyltrimethylammonium bromide (CTAB) surfactant layer. These nanorods were then 
wrapped with negatively charged polyacrylic acid (PAA) polyelectrolyte using layer by layer 
deposition technique [96]. Additional layers of polyallyamine hydrochloride (PAH) and (PAA) 
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were used as required. Stock solutions of PAA and PAH at concentrations of 10 mg/ml in 1 mM 
NaCl and a separate aqueous solution of 10 mM NaCl were prepared. As is evident from the 
SEM (Figure 5.17(c)), we achieved a separation (>100 nm) between adjacent nanorods that was 
sufficient to prevent dimer coupling.  
The PC surface was given an oxygen plasma treatment (100 W, 5 minutes). To form a 
positively charged surface, the PAH stock solution was drop cast onto PC substrate and left to 
dry overnight. The substrates were then rinsed with deionized water and left to dry in an oven set 
to 75 °C. A further negatively charged PAA polyelectrolyte was then also drop-cast onto the 
substrate and left to assemble for an hour. Excess PAA solution was removed by wicking with a 
kimwipe. Next, CTAB capped gold nanorods  (7.5 nM in nanoparticle concentration) were drop-
cast and left to complex on the substrate for 20 mins.  The PC was washed once again with 
deionized water and dried in an oven at 75 °C . Finally a Raman reporter solution of 10 mM 4,4'-
dipyridyl in water was drop-cast onto the substrate and incubated overnight in ambient 
conditions. The excess solution was wicked off using a kimwipe. The substrate was once again 
rinsed with deionized water and then air-dried.  
5.7.4 Detection setup and experimental results 
For experimental measurement of the enhancement effects of the PC, Raman spectra of 
4,4'-dipyridyl was measured and compared in the on- and off-resonance configurations for a PC 
with Au nanorods. The Raman detection instrument used was a modified version of a previously 
described line-scanning detection instrument for PC discussed in Section 5.5. The schematic of 
the instrument is shown in Figure 5.18(a). The illumination of this system consists of a 70 mw 
solid-state laser (AlGaAs) at 637 nm, coupled to a polarization maintaining fiber, a half wave 
plate, a cylindrical lens, a long pass dichroic mirror, and a 10× objective (Olympus Plan N) of 
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focal length 18 mm. The laser beam is collimated and passed through a half-wave plate, which is 
used to rotate the polarization of the beam to match with the TM mode of the PC. The laser beam 
is then focused to a line by the cylindrical lens (f=100 mm). The focused laser line is directed 
onto the back focal plane of the microscope objective via a dichroic mirror. The output of the 
objective is thus a laser beam focused to a line. The assembly comprising of the cylindrical lens, 
half-wave plate and fiber collimator is mounted on a motorized linear stage. To select for the 
resonance angle in the front focal plane of the objective, the line-focused beam is translated on 
the back focal plane of the objective by tuning the position of the aforementioned assembly. The 
PC sample, placed at the front focal plane of the infinity corrected objective, interacts with a 
beam such that it appears collimated in one plane but focused in the other. A bandpass 
fluorescence filter (Semrock) is placed after the objective to block the excitation laser beam. The 
scattered Raman signal is collected by the objective and directed towards a spectrometer (Horiba 
Scientific) via a projection lens. The PC is excited on-resonance at 7.2°; this is showcased in the 
reflected angle spectrum shown in Figure 5.18(b). We picked 10° to be the off-resonance 
illumination condition for this study. The Raman spectrum measured for the device both on- and 
off-resonance is shown in Figure 5.19. All the characteristic peaks between 800 and 1800 cm-1 
[97] are detectable for the on-resonance case; however, a few peaks are not distinguishable over 
the background for the off-resonance case.  The PC enhancement factor, calculated as the signal 
on-resonance divided by the signal off-resonance (after normalizing for background) was found 
to be ~7×.  
5.8 Conclusion 
In this chapter, we introduce a novel method for exploiting optical properties of a PC 
surface in the context of PCEF-based microarray analysis.  For the first time, a line-scanning 
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approach was used to couple light into a one-dimensional PC and subsequently generate 
enhanced fields close to the surface. The approach was chosen specifically for its higher power 
density relative to previously demonstrated collimated PCEF instruments without significantly 
sacrificing the coupling efficiency.  
The instrument was further improved by utilizing an objective-coupled design that 
allowed for higher resolution, compact size and flexibility in PC substrate selection (opaque or 
transparent). The instrument beam characteristics were documented and analyzed to understand 
the limitations of the instrument, both from a device coupling and an image acquisition 
standpoint.  The focus beam width was found to be 6 µm and predictably uniform over a 130 µm 
band in the center of a 1000 µm wide frame. Beyond this a robust image processing method was 
discussed that allows for increased uniformity in the image and artificially enhances the 
integration time.  
We briefly introduce a new silicon-based PC design, chosen for its ease of fabrication 
and promise for high-volume production. In order to characterize the wavelength spectrum of the 
new PC we designed a complementary white-light illumination setup. The setup along with the 
OCLS is used to characterize the resonance peak efficiency for the opaque silicon-based PC.  
To compare the OCLS performance with a commercial confocal scanner, we used a 
fluorescence nanoarray spotted on a PC and a glass slide. The Si-PC coupled with the OCLS 
showed a >10× improvement in the limit of detection compared to a glass slide measured on the 
confocal scanner. This was the first time a PC-based instrument outperformed the confocal 
scanner. The approach thus demonstrated our goal to improve upon current microarray 
technology. The combination of a silicon-based PC with a custom line-scanning instrument can 
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be an attractive alternative to current technology for a wide variety of surface-based fluorescence 
assays that would benefit from reduction of detection limits.  
To showcase the versatility of the OCLS we modified the setup to incorporate a 
spectrometer for Raman detection. The CCD was added at the exit port of the spectrometer, 
allowing for conventional imaging and spectral detection on the same system. To demonstrate 
the Raman detection capability of the OCLS we utilized a Si-PC with gold nanorods sparsely 
dispersed on its surface. The sensor allowed us to specifically take advantage of the PC’s ability 
to efficiently couple electric fields into the LSPR mode of Au nanorods on its surface. This fact 
was exploited to enhance the Raman scattering resulting from a monolayer of 4,4’-dipyridyl by a 
factor of 7.   
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5.9 Tables 
Table 5.1 Antigens, abbreviations and concentrations 
Antigen Abbreviation Max Conc. (ng/ml) 
Amphiregulin AmR 3.33 
Basic fibroblast growth factor bFGF 3.33 
CD14 CD14 16.67 
Epidermal growth factor EGF 0.83 
Epidermal growth factor receptor EGFR 4.17 
E-selectin Esel 4.17 
Heparin-binding epidermal growth factor HBEGF 0.83 
c-erbB-2 extracellular domain HER2 8.33 
Hepatocyte growth factor HGF 1.67 
Intercellular adhesion molecule 1 ICAM 16.67 
Insulin-like growth factor 1 IGF1 3.33 
Matrix metalloprotease 1 MMP1 16.67 
Matrix metalloprotease 2 MMP2 8.33 
Matrix metalloprotease 9 MMP9 8.33 
Platelet-derived growth factor AA PDGF 1.25 
Prostate specific antigen PSA 1.67 
Regulated on activation normal T-cell expressed 
and secreted 
RANTES 0.83 
Transforming growth factor alpha TGFα 0.83 
Tumor necrosis factor alpha TNFα 1.67 
Urokinase-type plasminogen receptor uPAR 8.33 
Vascular endothelial growth factor VEGF 3.33 
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Table 5.2 Tecan Fluorescence Signal: IL-3 
IL-3 (ng/ml) Net Signal Signal Standard Deviation 
16.67 26473.00 5495.27 
5.56 16937.33 1838.19 
1.85 6925.92 1545.96 
0.62 2507.00 614.16 
0.21 776.25 129.15 
 
Table 5.3 Tecan Fluorescence Signal: TNF-α 
TNF-α (ng/ml) Net Signal Signal Standard Deviation 
2.00 48684.75 3116.73 
0.67 36180.83 4864.60 
0.22 14502.92 770.62 
0.074 5071.75 223.70 
0.025 1430.25 378.08 
 
Table 5.4 OCLS Fluorescence Signal: IL-3 
IL-3 (ng/ml) Net Signal Signal Standard Deviation 
16.670 1460586.7 70335.9 
5.560 1371107.8 42983.0 
1.850 341062.9 11354.0 
0.620 103493.2 5426.5 
0.210 26885.1 2178.0 
0.069 4486.6 490.3 
0.023 5720.9 1041.6 
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Table 5.5 OCLS Fluorescence Signal: TNF-α 
TNF-α (ng/ml) Net Signal Signal Standard Deviation 
2 611552.7 17579.5 
0.67 271694.5 13314.2 
0.22 106287.3 5179.5 
0.074 18005.1 1720.3 
0.025 5368.2 566.5 
0.008 638.2 131.3 
0.0027 1627.4 337.3 
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5.10 Figures 
 
Figure 5.1 SNR for on- and off-resonance cases of a quartz PC and an unpatterned glass slide. 
The fluorescent spots were of PPL-Alexa 647 spots on a substrate with no surface chemistry. 
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Figure 5.2 (a) Schematic of the PC structure (not to scale). The grating is oriented along the x-
axis. (b) Photonic band diagram of the PC surface for φ = 0º and θ varied from 0º to 12º. (c) 
Photonic band diagram of the PC sensor for θ = 0º and φ varied from 0º to 12º.  
 
	  	  
104	  
 
Figure 5.3 (a) Photonic crystal enhanced line-scanner schematic. (b) Image of the line on a two-
dimensional CCD showing a narrow tightly focused line. (c) The intensity profile along the line 
and across the line. The line has a Gaussian profile in both directions. (d) A plot showing a 
comparison of the coupling efficiency to the resonant mode for a line focused beam and 
collimated beam. 
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Figure 5.4 The images of the 21 assays are shown for both (a) on- and (b) off-resonance 
illumination. (c) The signal intensity on- and off-resonance for each assay measured using the 
developed line-scanner. The on-resonance and off-resonance signal thresholds are indicated. 
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Figure 5.5 Objective-coupled line-scanning imaging instrument schematic. The incident beam 
path is clearly demarcated with red and the collection beam path is demarcated after the dichroic 
mirror with burgundy. The collection and illumination beam paths overlap in the region between 
the dichroic mirror and the photonic crystal.  
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Figure 5.6 (a) A scanned image of a silicon piece with Dye doped SU-8 and a USAF photomask 
pattern. The image indicates an intensity distribution z direction. (b) A graph showing the 
intensity distribution in the X (or scanning) and orthogonal Z directions. The intensity appears to 
show little variation in the X direction but has a broad Gaussian distribution in the Z direction. 
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Figure 5.7 (a) The fluorescent image of the line is shown in the figure. (b) The distribution of the 
line in the X and Z directions indicates a Gaussian distribution in both directions. The linewidth 
in the X is very narrow (6 µm) due to focusing. The Gaussian distribution in the Z is narrower 
than for the image in 5.5. This is due to the image-processing algorithm. 
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Figure 5.8 (a) Schematic diagram of the silicon PC surface. The grating structure is patterned in 
silicon dioxide silicon substrate with period and duty cycle of 360 nm and 36%, respectively. 
SEM image of the (b) side-view, (c) top-view and (d) cross-sectional view show the integrity of 
the structure. 
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Figure 5.9 (a) Atomic force micrograph of completed foundry-fabricated Si-PC. (b) Cross 
sectional plot showing 40 nm depth and 360 nm period. 
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Figure 5.10 Schematic diagram of the reflection setup used for capturing reflected wavelength 
spectra. 
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Figure 5.11 Transmitted and reflected wavelength spectra of a transparent ErV1 PC for (a) 
normal and (b) off-normal illumination. There is an intensity discrepancy that can be attributed 
to absorption and scattering. 
	  	  
113	  
 
Figure 5.12 (a) Reflected wavelength spectra of the Si-PC captured on and off normal. (b) 
Reflected angle spectra of the Si-PC captured at 637 nm. Data was normalized to a gold mirror.  
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Figure 5.13 Graph of the signal distribution in the focus direction of the line as it steps through 
three adjacent positions on the sample. The positions are 2 µm apart. The black curve indicates 
the summation of all these curves at each 2 µm wide pixel.  
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Figure 5.14 Representative fluorescence images of the nanoarray on the glass slide taken with 
the Tecan for (a) IL-3 at 1851.85 pg/ml and TNF-α at 222.22 pg/ml, and (b) IL-3 at 205.76 pg/ml 
and TNF-α at 24.69 pg/ml. The corresponding dose-response curves generated with Prism for the 
detectable concentrations on glass of (c) IL-3 and (d) TNF-α. Error bars represent one standard 
deviation from four replicate spots. Only 5 of the 7 assayed concentrations were detected.  
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Figure 5.15 Representative fluorescence images of the nanoarray on the PC taken with the OCLS 
for (a) IL-3 at 205.76 pg/ml and TNF-α at 24.69 pg/ml, and (b) IL-3 at 22.86 pg/ml TNF-α at 
2.74 pg/ml. The corresponding dose-response curves generated with Prism for the detectable 
concentrations on glass of (c) IL-3 and (d) TNF-α. Error bars represent one standard deviation 
from four replicate spots. The 4 lowest concentrations are outlined in blue and magnified. The 
red line is indicative of the background value. All 7 of the assayed concentrations were detected.  
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Figure 5.16 (a) Schematic diagram of the Si-PC surface. The grating structure is patterned in 
silicon dioxide silicon substrate with period and duty cycle of 360 nm and 65%, respectively. (b) 
SEM image of the cross-sectional view showing the integrity of the structure. (c) Wavelength 
reflection spectra of the PC on and off normal. 
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Figure 5.17 (a) A 3D schematic diagram with a macroscopic view of the Si-PC surface with the 
gold nanorods after the protocol is completed. (b) A 2D schematic representation (not to scale) of 
the different layers deposited on the TiO2. The nanorods are sandwiched between two layers of 
PAA. (c) SEM image of the top view showing the presence of nanorods, which are sparsely 
distributed on the surface. (Inset) A zoomed-in view of a single nanorod. (d) The absorption 
spectra of the nanorod, peaking at 638 nm. 
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Figure 5.18 (a) Schematic diagram of the OCLS. The setup has been modified with an imaging 
spectrometer linked to a CCD. (b) A plot of the angle spectrum captured using the OCLS is 
shown. The resonant angle is around 7.2° and is consistent with the wavelength spectrum 
measured previously. 
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Figure 5.19 The captured Raman spectra of 4,4’-dipyridyl for the on- and off-resonance cases. 
All the representative peaks are present for the on-resonance case and there is an enhancement 
for every peak. 
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CHAPTER 6: CONCLUDING REMARKS AND FUTURE OUTLOOK 
6.1 Concluding Remarks 
Cancer today is more prominent as a disease than at any time in our history. There has 
been a significant focus by the scientific and healthcare communities on research to diagnose, 
treat and cure patients suffering from cancer. Owing to these efforts, most types of cancer today 
are no longer a death sentence and are treatable if detected early enough. However, the early 
detection of cancer continues to be highly subjective and there is no conclusive diagnostic test 
for early stages. The work presented in this dissertation addresses one of the great healthcare 
challenges of our day: the development of an affordable point-of-care diagnostic tool for early 
detection of cancer.  
Blood-based cancer biomarkers are a promising means of early and quantifiable 
identification of site-specific cancer. The most promising path to sensitive detection of low-
concentration biomarkers was a fluorescence-based modality, embedded in an ELISA scheme. 
We noted here that the high individual specificity of these biomarkers, however, demands the use 
of personalized assays coupled with a point-of-care detection system. This further constrained 
our design criterion by demanding not just the previously determined sensitive fluorescence 
detection, but also a low-cost compact detection instrument. 
We identified PCEF as the best way forward to achieving these goals. We began our 
discussion by a model for predicting EF performance of a PC in the context of a given set of 
instrument parameters as well as insights into instrument-specific device design. The 
enhancement factor, critical for PCEF performance, is the combined effect of the PC Q-factor 
and the instrument angle of divergence. There are two significant implications of this fact. First, 
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it is evident that the device needs to be designed to match the instrument and vice-versa. The 
collimated instrument design showed better performance in fluorescence enhancement. 
However, for a given device, there is a limit to which one can increase enhancement by 
improving the instrument angle of divergence. Second, for a very high-Q device, while the 
achievable fluorescence enhancement is very high, it comes with the caveat of higher potential 
sensitivity and thus variability in resonance coupling conditions and hence fluorescence 
enhancement. To combat this we introduced a new angle-scanning scheme that allows optimal 
coupling to every pixel in a PC-based fluorescent image and addresses some of the uniformity 
issues.   
Building on our understanding of device-specific instrument design and angle-sensitivity 
of high-Q devices, we combined a label-free modality with the fluorescence modality of the 
collimated detection instrument. The method captured a label-free image, created by mapping the 
resonance angle differences on a pixel-by-pixel basis over the entire field of view, and used it as 
a mask to identify the on-spot and off-spot regions. The optical image processing technique was 
very effective for a single biomarker experiment, but was difficult to translate to a multiplexed 
microarray.  The label-free modality was, however, useful for quality control of the microarray, 
helping to identify discrepancies in binding densities of antibodies. The angle-scanning 
technique of the instrument optimized the fluorescent enhancement and accounted for variability 
in surface chemistry and capture spot density. While the coefficient of variation of replicate 
assays reduced by 20-99% compared to ordinary fluorescence microscopy and the lowest 
detectable biomarker concentrations were greatly lowered, there was still need for bettering these 
LODs. These LODs were only on par with (or in some case worse than) a glass slide scanned 
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with a confocal scanner. Furthermore, the instrument used was large and needed scaling down 
for a point-of-care detection scheme. 
First, in order to attempt lowering the detection limits, we sought to isolate the problem. 
The collimated illumination scheme, while critical for achieving high PC coupling and hence PC 
fluorescence enhancement, lends itself to low power density and poor image quality. The lower 
power density results in poorer SNR, a fact clearly seen when comparing fluorescence signal on 
a glass slide with a confocal scanner. The higher LODs are a direct result of poor SNR. It was, 
thus, critical to address this issue of power density in order improve LODs. We introduce a line-
scanning approach as a novel method for exploiting optical properties of a 1D PC without 
significantly sacrificing the coupling efficiency. The approach showed higher power density 
relative to the previously demonstrated collimated PCEF instrument. This, coupled with a high 
PC-enhancement, held the promise of better LODs.  
After demonstrating the prototype designs’ PC enhancement capability, the instrument 
was further improved by utilizing an objective-coupled design. This compact design was much 
more conducive to a translatable point-of-care system. Furthermore, the new configuration also 
allowed for higher resolution and flexibility in PC substrate selection (opaque or transparent). 
The instrument was thoroughly tested to determine its imaging resolution and identify the design 
limitations. Furthermore, an image-processing algorithm was introduced to improve image 
uniformity and enhance signal intensity.  
Finally, a biomarker detection study was conducted in order to compare the OCLS 
performance with a commercial confocal scanner. The fluorescence nanoarray was spotted on 
the newly designed Si-PC and a glass slide. The OCLS showed a >10× improvement in the LOD 
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compared to the confocal scanner. This was the first time a PC-based instrument decisively 
outperformed the confocal scanner in limits of detection.  
In order to diversify the applicability of the OCLS, we modified the setup to incorporate a 
Raman detection scheme. Raman detection based point-of-care sensing is an important potential 
avenue for expansion in disease diagnosis and prognosis as well as monitoring. A Si-PC sensor 
with sparse coating of gold nanorods on its surface was used to showcase the instruments ability 
to effectively enhance and collect the Raman scattering from 4,4’-dipyridyl monolayer.  
6.2 Future Work 
The results and analysis presented in this dissertation make a strong case for the utility of 
PC-based instrumentation as a scheme for early detection of cancer in a point-of-care setting. 
There is a potential for significantly improving the limits of detection in fluorescent assays and 
performance in Raman detection techniques. While applications to protein microarrays and 
Raman sensing have been proposed and demonstrated, these studies were proof-of-concept 
experiments to showcase the technology. There is room for integration of the OCLS system with 
a label-free modality for further improvement in detection limits.  Further applications in the 
booming fields of proteomics, drug discovery and point-of-care diagnostics are numerous.   
In a clinical context, the use of PCEF imaging for miniaturizing and improving a full 
microarray experiment is an obvious extension of the work presented here. While the current 
compact size of the fluorescence instrument is already impressive, this can be further scaled 
down to create a truly miniaturized point-of-care detection system. The instruments’ 
fluorescence detection sensitivity promises great inroads into early detection of cancer via 
protein biomarker assays. There is potential for further improvement in detection limits by 
integration of the OCLS system with a label-free modality.  In addition, while a more rigorous 
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study of the EF resolution may go hand in hand with such efforts, the high-resolution capability 
of the instrument can be further expanded, lending to single-molecule studies and cellular 
fluorescence imaging applications. The high-resolution, high-frame-rate acquisition should also 
enable multiplexed kinetic analysis in a microfluidic environment. The Raman imaging 
demonstration paves the way for new, hybrid-SERS substrates capable of greater enhancement in 
small volumes that are critical for enhanced Raman scattering from monolayers and single 
molecules. For this and the aforementioned applications, properly engineered PC-instrument 
interfacing will be crucial to success.  The principles for instrument design should therefore help 
to achieve these goals.   
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